
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-b3a36f11.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-d4f8bd56.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Pharmacokinetics and clinical efficacy of lorazepam in children with severe malaria and convulsions - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="993C895E7B2156230C895E000237D564.m_1" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="brjclinpharm">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2291276/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="British Journal of Clinical Pharmacology">
<meta name="citation_title" content="Pharmacokinetics and clinical efficacy of lorazepam in children with severe malaria and convulsions">
<meta name="citation_author" content="Simon N Muchohi">
<meta name="citation_author_institution" content="Kenya Medical Research Institute (KEMRI)/Wellcome Trust Research Programme, Centre for Geographic Medicine Research (Coast), Kilifi">
<meta name="citation_author" content="Kenneth Obiero">
<meta name="citation_author_institution" content="KEMRI Centre for Clinical Research/United States Army Medical Research Unit–Kenya (USAMRU–K), New Nyanza Provincial General Hospital, Kisumu, Kenya">
<meta name="citation_author" content="Charles R J C Newton">
<meta name="citation_author_institution" content="Kenya Medical Research Institute (KEMRI)/Wellcome Trust Research Programme, Centre for Geographic Medicine Research (Coast), Kilifi">
<meta name="citation_author_institution" content="Neurosciences Unit, The Wolfson Centre, Institute of Child Health, University College London, London, UK">
<meta name="citation_author" content="Bernhards R Ogutu">
<meta name="citation_author_institution" content="KEMRI Centre for Clinical Research/United States Army Medical Research Unit–Kenya (USAMRU–K), New Nyanza Provincial General Hospital, Kisumu, Kenya">
<meta name="citation_author" content="Geoffrey Edwards">
<meta name="citation_author_institution" content="Department of Pharmacology and Therapeutics, School of Biomedical Sciences, University of Liverpool, Liverpool, UK">
<meta name="citation_author_institution" content="Molecular and Biochemical Parasitology Research Group, Liverpool School of Tropical Medicine, Liverpool, UK">
<meta name="citation_author" content="Gilbert O Kokwaro">
<meta name="citation_author_institution" content="Kenya Medical Research Institute (KEMRI)/Wellcome Trust Research Programme, Centre for Geographic Medicine Research (Coast), Kilifi">
<meta name="citation_author_institution" content="Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, University of Nairobi, Nairobi, Kenya">
<meta name="citation_publication_date" content="2007 Jul 17">
<meta name="citation_volume" content="65">
<meta name="citation_issue" content="1">
<meta name="citation_firstpage" content="12">
<meta name="citation_doi" content="10.1111/j.1365-2125.2007.02966.x">
<meta name="citation_pmid" content="17635501">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC2291276/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC2291276/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC2291276/pdf/bcp0065-0012.pdf">
<meta name="description" content="To investigate the pharmacokinetics and clinical efficacy of intravenous (i.v.) and intramuscular (i.m.) lorazepam (LZP) in children with severe malaria and convulsions. Twenty-six children with severe malaria and convulsions lasting ≥5 min were ...">
<meta name="og:title" content="Pharmacokinetics and clinical efficacy of lorazepam in children with severe malaria and convulsions">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="To investigate the pharmacokinetics and clinical efficacy of intravenous (i.v.) and intramuscular (i.m.) lorazepam (LZP) in children with severe malaria and convulsions. Twenty-six children with severe malaria and convulsions lasting ≥5 min were ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC2291276/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <ul class="pmc-header__search__menu">
                <li>
                    <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                        Advanced Search
                    </a>
                </li>
                <li>
                    
                        <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                            Journal List
                        </a>
                    
                </li>
                <li>
                    
                        <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    
                </li>
            </ul>
        </div>
    </div>
</section>

        
    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="2291276">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1111/j.1365-2125.2007.02966.x"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/bcp0065-0012.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC2291276%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/2291276/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/2291276/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex">
                         <button
                                 type="button"
                                 class="usa-button usa-button--unstyled usa-tooltip display-flex"
                                 title="Permalink"
                                 data-position="bottom"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC2291276/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-brjclinpharm.jpg" alt="British Journal of Clinical Pharmacology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to British Journal of Clinical Pharmacology" title="Link to British Journal of Clinical Pharmacology" shape="default" href="http://www.blackwellpublishing.com/journal.asp?ref=0306-5251" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Br J Clin Pharmacol</button></div>. 2007 Jul 17;65(1):12–21. doi: <a href="https://doi.org/10.1111/j.1365-2125.2007.02966.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1111/j.1365-2125.2007.02966.x</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Br%20J%20Clin%20Pharmacol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Br%20J%20Clin%20Pharmacol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Br%20J%20Clin%20Pharmacol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Br%20J%20Clin%20Pharmacol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Pharmacokinetics and clinical efficacy of lorazepam in children with severe malaria and convulsions</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Muchohi%20SN%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Simon N Muchohi</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Simon N Muchohi</span></h3>
<div class="p">
<sup>1</sup>Kenya Medical Research Institute (KEMRI)/Wellcome Trust Research Programme, Centre for Geographic Medicine Research (Coast), Kilifi</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Muchohi%20SN%22%5BAuthor%5D" class="usa-link"><span class="name western">Simon N Muchohi</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Obiero%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Kenneth Obiero</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Kenneth Obiero</span></h3>
<div class="p">
<sup>2</sup>KEMRI Centre for Clinical Research/United States Army Medical Research Unit–Kenya (USAMRU–K), New Nyanza Provincial General Hospital, Kisumu, Kenya</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Obiero%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kenneth Obiero</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Newton%20CRJC%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Charles R J C Newton</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Charles R J C Newton</span></h3>
<div class="p">
<sup>1</sup>Kenya Medical Research Institute (KEMRI)/Wellcome Trust Research Programme, Centre for Geographic Medicine Research (Coast), Kilifi</div>
<div class="p">
<sup>3</sup>Neurosciences Unit, The Wolfson Centre, Institute of Child Health, University College London, London, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Newton%20CRJC%22%5BAuthor%5D" class="usa-link"><span class="name western">Charles R J C Newton</span></a>
</div>
</div>
<sup>1,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ogutu%20BR%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Bernhards R Ogutu</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Bernhards R Ogutu</span></h3>
<div class="p">
<sup>2</sup>KEMRI Centre for Clinical Research/United States Army Medical Research Unit–Kenya (USAMRU–K), New Nyanza Provincial General Hospital, Kisumu, Kenya</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ogutu%20BR%22%5BAuthor%5D" class="usa-link"><span class="name western">Bernhards R Ogutu</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Edwards%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Geoffrey Edwards</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Geoffrey Edwards</span></h3>
<div class="p">
<sup>4</sup>Department of Pharmacology and Therapeutics, School of Biomedical Sciences, University of Liverpool, Liverpool, UK</div>
<div class="p">
<sup>5</sup>Molecular and Biochemical Parasitology Research Group, Liverpool School of Tropical Medicine, Liverpool, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Edwards%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Geoffrey Edwards</span></a>
</div>
</div>
<sup>4,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kokwaro%20GO%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Gilbert O Kokwaro</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Gilbert O Kokwaro</span></h3>
<div class="p">
<sup>1</sup>Kenya Medical Research Institute (KEMRI)/Wellcome Trust Research Programme, Centre for Geographic Medicine Research (Coast), Kilifi</div>
<div class="p">
<sup>6</sup>Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, University of Nairobi, Nairobi, Kenya</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kokwaro%20GO%22%5BAuthor%5D" class="usa-link"><span class="name western">Gilbert O Kokwaro</span></a>
</div>
</div>
<sup>1,</sup><sup>6</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="au1">
<sup>1</sup>Kenya Medical Research Institute (KEMRI)/Wellcome Trust Research Programme, Centre for Geographic Medicine Research (Coast), Kilifi</div>
<div id="au2">
<sup>2</sup>KEMRI Centre for Clinical Research/United States Army Medical Research Unit–Kenya (USAMRU–K), New Nyanza Provincial General Hospital, Kisumu, Kenya</div>
<div id="au3">
<sup>3</sup>Neurosciences Unit, The Wolfson Centre, Institute of Child Health, University College London, London, UK</div>
<div id="au4">
<sup>4</sup>Department of Pharmacology and Therapeutics, School of Biomedical Sciences, University of Liverpool, Liverpool, UK</div>
<div id="au5">
<sup>5</sup>Molecular and Biochemical Parasitology Research Group, Liverpool School of Tropical Medicine, Liverpool, UK</div>
<div id="au6">
<sup>6</sup>Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, University of Nairobi, Nairobi, Kenya</div>
<div class="author-notes p"><div class="fn" id="cor1">
<sup>✉</sup><p class="display-inline"><strong>Correspondence</strong> Dr Simon Ndirangu Muchohi, KEMRI/Wellcome Trust Research Programme, Centre for Geographic Medicine Research (Coast), PO Box 230, 80108–Kilifi, Kenya. Tel: + 254 41 52 2535/52 2063/52 5043 Fax: + 254 41 52 2390 E-mail: <span>sndirangu@kilifi.kemri-wellcome.org</span></p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2006 Aug 11; Accepted 2007 Apr 18; Issue date 2008 Jan.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2007 The Authors Journal compilation © 2007 Blackwell Publishing Ltd</div>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC2291276  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/17635501/" class="usa-link">17635501</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">AIM</h3>
<p>To investigate the pharmacokinetics and clinical efficacy of intravenous (i.v.) and intramuscular (i.m.) lorazepam (LZP) in children with severe malaria and convulsions.</p></section><section id="sec2"><h3 class="pmc_sec_title">METHODS</h3>
<p>Twenty-six children with severe malaria and convulsions lasting ≥5 min were studied. Fifteen children were given a single dose (0.1 mg kg<sup>−1</sup>) of i.v. LZP and 11 received a similar i.m. dose. Blood samples were collected over 72 h for determination of plasma LZP concentrations. Plasma LZP concentration–time data were fitted using compartmental models.</p></section><section id="sec3"><h3 class="pmc_sec_title">RESULTS</h3>
<p>Median [95% confidence interval (CI)] LZP concentrations of 65.1 ng ml<sup>−1</sup> (50.2, 107.0) and 41.4 ng ml<sup>−1</sup> (22.0, 103.0) were attained within median (95% CI) times of 30 min (10, 40) and 25 min (20, 60) following i.v. and i.m. administration, respectively. Concentrations were maintained above the reported therapeutic concentration (30 ng ml<sup>−1</sup>) for at least 8 h after dosing via either route. The relative bioavailability of i.m. LZP was 89%. A single dose of LZP was effective for rapid termination of convulsions in all children and prevention of seizure recurrence for &gt;72 h in 11 of 15 children (73%, i.v.) and 10 of 11 children (91%, i.m), without any clinically apparent respiratory depression or hypotension. Three children (12%) died.</p></section><section id="sec4"><h3 class="pmc_sec_title">CONCLUSION</h3>
<p>Administration of LZP (0.1 mg kg<sup>−1</sup>) resulted in rapid achievement of plasma LZP concentrations within the reported effective therapeutic range without significant cardiorespiratory effects. I.m administration of LZP may be more practical in rural healthcare facilities in Africa, where venous access may not be feasible.</p>
<section class="bt xbox font-sm" id="boxed-text1"><section id="sec5"><h4 class="pmc_sec_title">WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT</h4>
<ul class="list" style="list-style-type:disc">
<li><p>Lorazepam (LZP) may be a more useful anticonvulsant to stop convulsions in children with severe malaria (SM) than diazepam, since it has a longer duration of action and can be given by other routes, such as intramuscular (i.m.).</p></li>
<li><p>There are no studies describing both the pharmacoknetics and clinical efficacy of LZP in African children, particularly those with SM.</p></li>
<li><p>We have undertaken a study with LZP, administered either intravenously (i.v.) or i.m., to children with SM and convulsions in order to describe and compare the pharmacokinetic profiles of LZP following administration via both routes and determine whether the currently recommended dose of LZP (0.1 mg kg<sup>−1</sup>) is effective in terminating convulsions in this group.</p></li>
</ul></section></section><section class="bt xbox font-sm" id="boxed-text2"><section id="sec6"><h4 class="pmc_sec_title">WHAT THIS STUDY ADDS</h4>
<ul class="list" style="list-style-type:disc">
<li><p>Administration of LZP (i.v. or i.m.) at the currently recommended dose (0.1 mg kg<sup>−1</sup>) resulted in rapid achievement of plasma LZP concentrations within the reported effective therapeutic range without clinically significant cardiorespiratory effects.</p></li>
<li><p>A single dose of LZP was effective in the rapid termination of convulsions in all children, and prevention of seizure recurrence for &gt;72 h in 11 of 15 (73%) children and 10 of 11 (91%) children after i.v. and i.m. administration, respectively.</p></li>
</ul></section></section></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> children, convulsions, lorazepam, malaria, pharmacokinetics</p></section></section><section id="sec7"><h2 class="pmc_sec_title">Introduction</h2>
<p>Acute seizures are a frequent clinical feature of severe malaria (SM) and other infections in children [<a href="#b1" class="usa-link" aria-describedby="b1">1</a>]. Over 80% of children presenting to hospital with cerebral malaria have a history of seizures [<a href="#b2" class="usa-link" aria-describedby="b2">2</a>] and about 60% have clinical seizures after admission [<a href="#b1" class="usa-link" aria-describedby="b1">1</a>, <a href="#b3" class="usa-link" aria-describedby="b3">3</a>]. Protracted and multiple convulsions are often refractory to treatment and are associated with an increased risk of death [<a href="#b4" class="usa-link" aria-describedby="b4">4</a>] and/or neurological and cognitive deficits among survivors [<a href="#b5" class="usa-link" aria-describedby="b5">5</a>, <a href="#b6" class="usa-link" aria-describedby="b6">6</a>]. Therefore, early, prompt and effective termination and prevention of convulsions may improve outcome in children with SM. Furthermore, rapid and sustained seizure control may avert the need for multiple anticonvulsant administration and prolonged hospitalization.</p>
<p>The ideal drug for treating acute seizures and status epilepticus (SE) should: (i) enter the brain rapidly; (ii) have an immediate onset of anticonvulsant action; (iii) have minimal depression of consciousness or cardiorespiratory function; (iv) have a sustained duration of anticonvulsant action to prevent seizure recurrence; and (v) be easily and safely administered at peripheral healthcare facilities [<a href="#b7" class="usa-link" aria-describedby="b7">7</a>]. Benzodiazepines are considered the drugs of choice for rapid termination of acute seizures and SE [<a href="#b8" class="usa-link" aria-describedby="b8">8</a>]. In resource-poor countries, diazepam (DZ) is frequently used as the standard first-line treatment for acute convulsions and SE, as it is widely available, cheap and rapidly acting. However, it has several disadvantages. Gaining intravenous (i.v.) access is often technically difficult in most peripheral healthcare settings (with limited resources and healthcare personnel), particularly in young children who are having generalized tonic-clonic convulsions. Following i.v. administration, DZ is rapidly redistributed to lipoid tissues, and consequently, plasma concentrations rapidly decline with breakthrough seizures occurring when the concentrations fall below threshold levels [<a href="#b9" class="usa-link" aria-describedby="b9">9</a>]. Accordingly, repeated injections or continuous infusions are often required for sustained control of seizures. However, administration of multiple doses of DZ is undesirable, especially in children with SM, due to accumulation and increased risk of fatal respiratory depression [<a href="#b2" class="usa-link" aria-describedby="b2">2</a>, <a href="#b10" class="usa-link" aria-describedby="b10">10</a>]. Moreover, rectal administration of DZ (which has been suggested as a practical alternative to i.v. administration under such settings) generally results in variable absorption, leading to rapid recurrence of seizures [<a href="#b9" class="usa-link" aria-describedby="b9">9</a>]. The intramuscular (i.m.) route, which is frequently used in such settings, is not suitable for administration of DZ for termination of acute seizures and SE, since it results in incomplete and erratic absorption [<a href="#b11" class="usa-link" aria-describedby="b11">11</a>].</p>
<p>Lorazepam (LZP) has several advantages over DZ. Lorazepam is less lipid-soluble than DZ and, following i.v. administration, it has a longer duration of anticonvulsant action (12–24 h) than predicted from its elimination half-life [<a href="#b12" class="usa-link" aria-describedby="b12">12</a>]. It prevents seizure recurrence for between 2 and 72 h [<a href="#b13" class="usa-link" aria-describedby="b13">13</a>] and can be used for both acute treatment and prophylaxis of seizures. It has potent anticonvulsant activity and is effective in management of SE in both adults [<a href="#b14" class="usa-link" aria-describedby="b14">14</a>–<a href="#b16" class="usa-link" aria-describedby="b16">16</a>] and children [<a href="#b17" class="usa-link" aria-describedby="b17">17</a>], including SE refractory to phenobarbital and phenytoin [<a href="#b18" class="usa-link" aria-describedby="b18">18</a>]. I.v. and intranasal LZP has been successfully used in acute seizures and SE in the emergency room for children [<a href="#b19" class="usa-link" aria-describedby="b19">19</a>, <a href="#b20" class="usa-link" aria-describedby="b20">20</a>] and has been shown to be more effective than DZ for out-of-hospital treatment of SE in adults [<a href="#b21" class="usa-link" aria-describedby="b21">21</a>]. LZP may be associated with less respiratory depression than DZ [<a href="#b14" class="usa-link" aria-describedby="b14">14</a>, <a href="#b17" class="usa-link" aria-describedby="b17">17</a>, <a href="#b22" class="usa-link" aria-describedby="b22">22</a>–<a href="#b24" class="usa-link" aria-describedby="b24">24</a>].</p>
<p>To date, no studies have been reported describing both the pharmacokinetics and clinical efficacy of LZP in African children, particularly those with SM. The pharmacokinetics of LZP may be altered in children, and a few concentration-dependent side-effects such as respiratory depression have been reported in infants and children [<a href="#b25" class="usa-link" aria-describedby="b25">25</a>, <a href="#b26" class="usa-link" aria-describedby="b26">26</a>]. Children with SM may have compromised respiratory function and hypotension due to associated metabolic acidosis [<a href="#b27" class="usa-link" aria-describedby="b27">27</a>] and intracranial hypertension [<a href="#b28" class="usa-link" aria-describedby="b28">28</a>], which may be aggravated by LZP.</p>
<p>We have undertaken a study on LZP administered by either the i.v. or i.m. route to children with SM and convulsions in order to: (i) describe and compare the pharmacokinetic profiles of LZP following administration via both routes; (ii) determine whether the currently recommended dose of LZP (0.1 mg kg<sup>−1</sup>) is effective in terminating convulsions in this group; (iii) correlate LZP plasma concentrations with termination and recurrence of convulsions, and respiratory and cardiovascular parameters; and (iv) determine whether the i.m. route would provide a comparable bioavailability and pharmacokinetic profile with respect to the i.v. route.</p></section><section id="sec8"><h2 class="pmc_sec_title">Methods</h2>
<section id="sec9"><h3 class="pmc_sec_title">Study site and study design</h3>
<p>This was an open-label, nonrandomized, uncontrolled study. The Kenya Medical Research Institute (KEMRI) Scientific Steering Committee, KEMRI/National Ethical Review Committee and the Research Ethics Committee (Liverpool School of Tropical Medicine, Liverpool, UK) approved the study, which was conducted at the paediatric ward of the New Nyanza Provincial General Hospital (NNPGH), Kisumu (a town with a population of approximately 320 000 people) located on the shores of Lake Victoria in Western Kenya. The NNPGH, the main government tertiary referral hospital (400 beds), serves the entire western Kenya region. The hospital includes a 44-bed paediatric inpatient ward, which admits an average of 8000 children annually, of whom about 40% have falciparum malaria (B. R. Ogutu, personal communication). Government-employed and medically qualified clinical and nursing personnel provide inpatient paediatric medical care to children admitted to the paediatric unit, including the study participants. In addition, a qualified and experienced research nurse (trained in intensive care unit skills and with broad experience in paediatric care in a research setting) was primarily responsible for blood sample collection and close monitoring of the study participants.</p></section><section id="sec10"><h3 class="pmc_sec_title">Study participants</h3>
<p>All children admitted to the NNPGH paediatric unit were eligible for the study if: (i) they were aged between 6 months and 13 years; (ii) they had signs of SM (prostration: unable to sit, drink or breast-feed, but conscious; respiratory distress, or deep (acidotic) breathing) [<a href="#b29" class="usa-link" aria-describedby="b29">29</a>, <a href="#b30" class="usa-link" aria-describedby="b30">30</a>]; (iii) they had a convulsion lasting ≥5 min; and (iv) the child's parent(s)/guardian(s) gave written informed consent. Informed consent was obtained from the parents/guardians in a language of their choice, and children were recruited with intent to treat. Children were excluded if: (i) they had received DZ prior to admission to NNPGH (documented in referral case notes, or from the history of the current illness); (ii) informed consent could not be obtained from parents/guardians; and (iii) they had compromised cardiorespiratory function (which, in the opinion of the clinician attending to the child, could be exacerbated by a benzodiazepine). Children exited the study if informed consent was withdrawn or were excluded at the data analysis stage if LZP was detected in the baseline (predose) plasma sample.</p></section><section id="sec11"><h3 class="pmc_sec_title">Clinical care</h3>
<p>All children admitted to the ward were assessed by a medically qualified member of the paediatric team. A clinical history was taken and complete physical examination performed on all children on admission. Venous access was obtained by fixing F.E.P. polymer cannulae (Ven-O-Lit®; MIGADA, Kiryat Shmona, Israel), one for i.v. fluids and drug administration and another (in the opposite arm) for blood sampling. A single blood sample (4 ml) was drawn for quantitative parasite count, blood culture and full haemogram. A portion of the blood (0.5 ml) was centrifuged (1500 <em>g</em>; 5 min) and the plasma stored at −20°C until assayed for baseline LZP concentrations.</p>
<p>All children received antimalarial treatment with quinine dihydrochloride (Lincoln Pharmaceuticals Ltd, Gandhinagar, India) as a loading dose (15 mg kg<sup>−1</sup> diluted with 10 ml kg<sup>−1</sup> of 5% dextrose saline) infused over 4 h, followed by a maintenance dose (10 mg kg<sup>−1</sup> in 10 ml kg<sup>−1</sup> 5% dextrose saline) infused over 4 h every 8 hours [<a href="#b31" class="usa-link" aria-describedby="b31">31</a>], until the child could take oral drugs when antimalarial treatment was completed with first line antimalarial drugs. Other antimalarial drugs including artemisinin derivatives (dihydroartemisin) and amodiaquine were prescribed as required (at the discretion of the clinician attending the child). Severe anaemia (Hb ≤50 g l<sup>−1</sup>) was corrected with a blood transfusion (20 ml kg<sup>−1</sup>) infused over 4 h [<a href="#b32" class="usa-link" aria-describedby="b32">32</a>, <a href="#b33" class="usa-link" aria-describedby="b33">33</a>]. All children were treated with broad-spectrum antibiotics (chloramphenicol, 25 mg kg<sup>−1</sup> 6-hourly; and benzyl penicillin) as presumptive treatment for bacteraemia or meningitis [<a href="#b34" class="usa-link" aria-describedby="b34">34</a>, <a href="#b35" class="usa-link" aria-describedby="b35">35</a>] until cerebrospinal fluid and blood culture results were available. Children with fever (temperature &gt;38.5°C) were treated with paracetamol (15 mg kg<sup>−1</sup>) administered orally, exposure, and tepid sponging. Hypoxia was corrected with 100% oxygen administered by nasal prongs.</p>
<p>Children with convulsions lasting ≥5 min were treated with a single dose (0.1 mg kg<sup>−1</sup>) of LZP (Ativan™; 4 mg LZP BP ml<sup>−1</sup>; Wyeth Laboratories, Maidenhead, UK) administered either intravenously as a slow bolus over 1–2 min (to avoid inducing respiratory depression) or as a deep i.m. injection into the anterior aspect of the thigh. If the convulsion did not stop within 10–15 min after LZP administration, i.v. DZ (0.3 mg kg<sup>−1</sup>) was administered as a slow bolus over 1–2 min. Convulsions that were refractory to treatment with both LZP and DZ, or those that recurred within the 72-h study period following administration of LZP, were treated with a single dose (15 mg kg<sup>−1</sup>) of i.m. phenobarbital (100 mg ml<sup>−1</sup>; Lab Renaudin, St Claud, France). The child was closely monitored for any signs of adverse effects, such as respiratory depression.</p>
<p>Other second- or third-line anticonvulsants, including paraldehyde, phenytoin and sodium valproate, were not available as part of the hospital's routine seizure treatment protocol. Ideally, phenytoin should only be given intravenously together with cardiac monitoring (which is lacking in most health facilities where SM malaria is treated in sub-Saharan Africa, including the present study site).</p></section><section id="sec12"><h3 class="pmc_sec_title">Blood sampling</h3>
<p>Venous blood samples (0.75 ml) for the determination of plasma unconjugated LZP concentrations were collected predose and at 10, 20, 30, 40, 60 min and 2, 4, 6, 8, 12, 24, 36, 48, 60 and 72 h after LZP administration. The cannula was flushed with sterile heparinized normal saline solution (1.0 ml; 20 IU ml<sup>−1</sup>). The blood was mixed in lithium-heparinized tubes and centrifuged immediately (1500 <em>g</em>; 5 min) at room temperature. The plasma was separated into polypropylene tubes and stored at −20°C until analysis for unconjugated LZP and paracetamol.</p></section><section id="sec13"><h3 class="pmc_sec_title">Clinical measurements</h3>
<p>All children had respiratory and pulse rates, blood pressure and level of consciousness (Blantyre coma score) [<a href="#b36" class="usa-link" aria-describedby="b36">36</a>, <a href="#b37" class="usa-link" aria-describedby="b37">37</a>] recorded at every blood sampling point. In addition, the presence, duration and pattern of convulsions were recorded. Respiratory depression was defined as requiring oxygen by bag and mask, or a poor respiratory effort and reduced respiratory rate following cessation of convulsions (this definition was primarily subjective and did not include routine blood-gas analysis, because facilities for this service were unavailable). Efficacy was assessed using the following measures: (i) the number of children whose convulsions were controlled by a single dose of LZP; (ii) latency (time from initial LZP injection to termination of the seizure); (iii) the use of additional anticonvulsants to control the initial convulsion; (iv) the number of seizures recurring within 72 h after LZP administration; and (v) the duration of seizure control. In a few cases, patients received a second or third anticonvulsant (DZ and/or phenobarbital) after the single dose of LZP. Therefore, the outcome of seizure control was reported descriptively, such as ‘complete control’ or ‘no recurrence’. A successful treatment was defined as one in which the seizure clinically ceased within 15 min after drug administration requiring no further treatment.</p></section><section id="sec14"><h3 class="pmc_sec_title">Determination of lorazepam and paracetamol concentrations in plasma</h3>
<p>The plasma concentrations of unconjugated LZP were measured using sensitive and selective reversed-phase high-performance liquid chromatography with ultraviolet detection [<a href="#b38" class="usa-link" aria-describedby="b38">38</a>]. In brief, LZP and the internal standard (oxazepam) were extracted from alkalinized plasma (pH 9.5) into an organic solvent (<em>n</em>-hexane–dichloromethane; 70 : 30%, v/v). After evaporation of the solvent under white spot nitrogen gas, the residue was reconstituted in mobile phase (100 µl) and a 50-µl aliquot was injected. Chromatographic separation was performed on a C18 reversed-phase analytical column (Synergi™ Max RP; 150 × 4.6 mm i.d.; 4 µm particle size; Phenomenex®, Macclesfield, UK) using an aqueous mobile phase [10 m<span class="font-variant-small-caps">m</span> KH<sub>2</sub>PO<sub>4</sub> buffer (pH 2.4)–acetonitrile; 65 : 35%, v/v] delivered at a flow rate of 2.5 ml min<sup>−1</sup>. The limit of quantification of LZP was 10 ng ml<sup>−1</sup>. Calibration curves were linear over the range 10–300 ng (<em>r</em><sup>2</sup> = 0.99). Lorazepam quality control (QC) samples corresponding to low (LQC), medium (MQC) and high (HQC) concentrations on the calibration curve were 20, 150 and 270 ng ml<sup>−1</sup>, respectively. The intra-assay coefficients of variation (CVs) at 20, 150 and 270 ng ml<sup>−1</sup> of LZP were 7.8%, 9.8% (<em>n</em> = 7 in both cases) and 6.6% (<em>n</em> = 8), respectively. The interassay CVs at the above concentrations were 15.9%, 7.7% and 8.4% (<em>n</em> = 7 in all cases), respectively. The method is selective for LZP, with no interference from other commonly coadministered anticonvulsant, antimicrobial, antipyretic or antimalarial drugs.</p>
<p>Both LZP and paracetamol are eliminated via conjugation with glucuronic acid. Some patients administered LZP were also given paracetamol as an antipyretic. Plasma paracetamol concentrations were measured using an Abbott TDx FLx® fluorescence polarization immunoassay analyser (Abbott Laboratories, Diagnostics Division, Abbott Park, IL, USA). The target (range) concentrations for low (L), medium (M) and high (H) QC samples were 15.0 (12.70–17.30), 35.0 (31.5–38.5) and 150.0 µg ml<sup>−1</sup> (135.0–165.0), respectively. The nominal concentrations for the paracetamol calibrators were 0, 10, 20, 50, 100 and 200 µg ml<sup>−1</sup>. The manufacturer supplied the samples for calibration and QC samples. The method is reported to have a sensitivity of 1.0 µg ml<sup>−1</sup>.</p></section><section id="sec15"><h3 class="pmc_sec_title">Pharmacokinetic analysis</h3>
<p>Following i.v. administration, the LZP plasma concentration–time data were fitted to a two-compartmental model with elimination from the central compartment, according to the following equation:
</p>
<table class="disp-formula p" id="disp-formula1"><tr><td class="formula"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50fc/2291276/2bafeffd36b8/bcp0065-0012-mu1.jpg" loading="lazy" height="33" width="183" alt="graphic file with name bcp0065-0012-mu1.jpg"></td></tr></table>
<p>
where <em>C</em><sub>p</sub> is the plasma LZP concentration at time (<em>t</em>) and the subscripts 1 and 2 refer to the first and second exponential terms, and <em>C</em><sub>1</sub> and <em>C</em><sub>2</sub> refer to the corresponding zero-time intercepts or coefficients [<a href="#b39" class="usa-link" aria-describedby="b39">39</a>]. In the present case, λ<sub>2</sub> = λ<sub>z</sub> = terminal elimination rate constant.</p>
<p>The plasma LZP concentration–time data were fitted to the above model using the pharmacokinetic data-fitting program TopFit [<a href="#b40" class="usa-link" aria-describedby="b40">40</a>]. Reciprocal weighting was used for the concentration data. The area under the plasma LZP concentration–time curve from time zero to infinity (AUC<sub>0–∞</sub>) was estimated using the linear trapezoidal method [<a href="#b41" class="usa-link" aria-describedby="b41">41</a>]. The model of best fit was selected on the basis of Akaike information criterion [<a href="#b42" class="usa-link" aria-describedby="b42">42</a>]. Estimates of the elimination half-life (<em>t</em><sub>1/2,λz</sub>), apparent volume of distribution of the central compartment (<em>V</em><sub>c</sub>), steady-state volume of distribution (<em>V</em><strong><sub>ss</sub></strong>) and clearance (CL) for i.v. administration were obtained using standard pharmacokinetic equations.</p>
<p>A one-compartment model with an absorption phase and an elimination phase was used to fit the concentration–time data following i.m. administration of LZP according to the following equation:
</p>
<table class="disp-formula p" id="disp-formula2"><tr><td class="formula"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50fc/2291276/8836ded40265/bcp0065-0012-mu2.jpg" loading="lazy" height="56" width="381" alt="graphic file with name bcp0065-0012-mu2.jpg"></td></tr></table>
<p>
where <em>F</em> = fraction of administered dose which is bioavailable, <em>D</em> = dose administered, <em>V</em> = apparent volume of distribution, <em>k</em><sub><em>a</em></sub> = first order absorption rate constant, <em>K</em> = first order elimination rate constant, and <em>t</em><sub>lag</sub> = lag time before commencement of absorption.</p>
<p>The concentration–time data were fitted into the model using TopFit [<a href="#b40" class="usa-link" aria-describedby="b40">40</a>]. Values for the maximum plasma LZP concentration (<em>C</em><sub>max</sub>) and the corresponding time to <em>C</em><sub>max</sub> (<em>t</em><sub>max</sub>) were determined directly by visual inspection of the concentration <em>vs.</em> time data for each participant. The relative bioavailability of LZP following i.m. administration (<em>F</em><sub>i.m.</sub>) was calculated using the formula:
</p>
<table class="disp-formula p" id="disp-formula3"><tr><td class="formula"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50fc/2291276/30ed806adb46/bcp0065-0012-mu3.jpg" loading="lazy" height="31" width="358" alt="graphic file with name bcp0065-0012-mu3.jpg"></td></tr></table></section><section id="sec16"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p>All pharmacokinetic parameters were summarized using descriptive statistics. The 95% confidence intervals (CI) for the differences between the means of the pharmacokinetic parameters were calculated using the commercially available computer program Confidence Interval Analysis [<a href="#b43" class="usa-link" aria-describedby="b43">43</a>]. The Mann–Whitney <em>U</em>-test was used to compare demographic and pharmacokinetic parameters between the i.v. and i.m. treatment groups, using the Stata™ (version 8.2) statistical/data analysis program (Stata Corp., College Station, TX, USA). A <em>P</em>-value of &lt;0.05 was considered to be statistically significant.</p></section></section><section id="sec17"><h2 class="pmc_sec_title">Results</h2>
<section id="sec18"><h3 class="pmc_sec_title">Demographics</h3>
<p>Twenty-six children, median age 30 months (range 6–76) were recruited into the study: 15 (M/F, 6/9) in the i.v. and 11 (M/F, 5/6) in the i.m. LZP group. <a href="#tbl1" class="usa-link">Table 1</a> summarizes the demographic characteristics of the patients in each group. No statistically significant differences were observed between the two groups.</p>
<section class="tw xbox font-sm" id="tbl1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Demographic characteristics and biochemical parameters of children administered a single dose (0.1 mg kg<sup>−1</sup>) of lorazepam either intravenously (i.v.) or intramuscularly (i.m.)</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th rowspan="1" colspan="1"></th>
<th align="left" colspan="2" rowspan="1">I.v. lorazepam</th>
<th align="left" colspan="2" rowspan="1">I.m. lorazepam</th>
<th align="left" rowspan="1" colspan="1">95% CI for the difference between the means or median</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>Number of children</strong></td>
<td align="left" rowspan="1" colspan="1">15</td>
<td rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">11</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr><td align="left" colspan="6" rowspan="1"><strong>Demography</strong></td></tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>    Sex (M/F)</strong></td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">6 : 9</td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">6 : 5</td>
<td align="left" rowspan="1" colspan="1">–</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>    Age (months)</strong></td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">32.0 (8–91)</td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">28.0 (6–78)</td>
<td align="left" rowspan="1" colspan="1">−16.0, 16.0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>    Weight (kg)</strong></td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">10.8 (9.2, 12.4)</td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">11.1 (8.5, 13.7)</td>
<td align="left" rowspan="1" colspan="1">−3.07, 2.44</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>    Axillary temperature (°C)</strong></td>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">37.6 (37.1, 38.1)</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">37.9 (37.1, 38.8)</td>
<td align="left" rowspan="1" colspan="1">−1.25, 0.54</td>
</tr>
<tr><td align="left" colspan="6" rowspan="1"><strong>Laboratory parameters</strong></td></tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>    Haemoglobin (g dl<sup>−1</sup>)</strong></td>
<td align="left" rowspan="1" colspan="1">14</td>
<td align="center" rowspan="1" colspan="1">6.9 (5.2, 8.6)</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="center" rowspan="1" colspan="1">8.4 (6.5, 10.5)</td>
<td align="left" rowspan="1" colspan="1">−4.21, 1.03</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>    RBC (×10<sup>6</sup>) µl<sup>−1</sup></strong></td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">3.14 (2.34, 3.93)</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">3.87 (3.12, 4.63)</td>
<td align="left" rowspan="1" colspan="1">−1.87, 0.40</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>    WBC (×10<sup>6</sup>) l<sup>−1</sup></strong></td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">10.3 (6.9, 13.6)</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="center" rowspan="1" colspan="1">9.7 (4.5, 14.8)</td>
<td align="left" rowspan="1" colspan="1">−4.77, 5.99</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn1"><p>Values are expressed as mean [95% confidence interval (CI)], except age, which is expressed as median (range). RBC, Red blood cells; WBC, white blood cells.</p></div></div></section></section><section id="sec19"><h3 class="pmc_sec_title">Seizure control</h3>
<p>Administration of a single dose of LZP (i.v. or i.m.) resulted in complete cessation of seizures in all the children in both groups (<a href="#tbl2" class="usa-link">Table 2</a>). The median time to seizure cessation was 8 min (range 3–16 min) and 9 min (range 6–27 min) following i.v. and i.m. administration, respectively. Seizures recurred in four of 15 (27%) children following i.v. administration, while none of the children in the i.m. group experienced recurrence of seizures. The median time for recurrence of seizures was 67.5 min (range 40–120). Of the four children whose convulsions recurred after a single i.v. dose of LZP, two were administered i.v. DZ but seizures were not controlled. Thus, in all the four children, convulsions were terminated with a single dose of i.m. phenobarbital (15 mg kg<sup>−1</sup>). One child whose seizures had been effectively terminated with i.v. LZP absconded after 12 h; the patient was excluded in the assessment of prophylaxis against seizure over the 72-h study period. A 72-h seizure-free interval was observed in 11 of 15 (73%) and 10 of 11 (91%) children after i.v. and i.m. administration of LZP, respectively.</p>
<section class="tw xbox font-sm" id="tbl2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Clinical progress and outcome</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th rowspan="1" colspan="1"></th>
<th align="left" rowspan="1" colspan="1">I.v. lorazepam</th>
<th align="left" rowspan="1" colspan="1">I.m. lorazepam</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>Number of children</strong></td>
<td align="center" rowspan="1" colspan="1">15</td>
<td align="center" rowspan="1" colspan="1">11</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>Blantyre coma score at time 0</strong></td>
<td align="center" rowspan="1" colspan="1">0 (0–1)*</td>
<td align="center" rowspan="1" colspan="1">0 (0–1)*</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>Blood transfusion</strong></td>
<td align="center" rowspan="1" colspan="1">4 (27%)</td>
<td align="center" rowspan="1" colspan="1">1 (9%)</td>
</tr>
<tr><td align="left" colspan="3" rowspan="1"><strong>Clinical outcome</strong></td></tr>
<tr><td align="left" colspan="3" rowspan="1"><strong>    Patients with convulsions controlled with single dose of LZP within:</strong></td></tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>     15 min</strong></td>
<td align="center" rowspan="1" colspan="1">14 (93%)</td>
<td align="center" rowspan="1" colspan="1">7 (64%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>     27 min</strong></td>
<td align="center" rowspan="1" colspan="1">15 (100%)</td>
<td align="center" rowspan="1" colspan="1">11 (100%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>Latency (time from initial LZP injection to seizure control), min</strong></td>
<td align="center" rowspan="1" colspan="1">8 (3–16)*</td>
<td align="center" rowspan="1" colspan="1">9 (6–27)*</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>    Patients with recurrence of convulsions</strong></td>
<td align="center" rowspan="1" colspan="1">4 (27%)</td>
<td align="center" rowspan="1" colspan="1">0 (0%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>    Time to seizure recurrence, min; <em>n</em> = 4</strong></td>
<td align="center" rowspan="1" colspan="1">67.5 (40–120)</td>
<td align="center" rowspan="1" colspan="1">–</td>
</tr>
<tr><td align="left" colspan="3" rowspan="1"><strong>    Patients requiring additional anticonvulsants</strong></td></tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>     Diazepam</strong></td>
<td align="center" rowspan="1" colspan="1">2 (13%)</td>
<td align="center" rowspan="1" colspan="1">0 (0%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>     Phenobarbital</strong></td>
<td align="center" rowspan="1" colspan="1">4 (27%)</td>
<td align="center" rowspan="1" colspan="1">0 (0%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>    Duration of seizure control of LZP, h</strong></td>
<td align="center" rowspan="1" colspan="1">≥72 h; <em>n</em> = 11</td>
<td align="center" rowspan="1" colspan="1">≥72 h; <em>n</em> = 10</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>    Patients with respiratory depression</strong></td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>    Deaths</strong></td>
<td align="center" rowspan="1" colspan="1">2 (13%)</td>
<td align="center" rowspan="1" colspan="1">1 (9%)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn2"><p>Values are presented as number (percentage), mean (95% CI) † or median (range)*.</p></div></div></section></section><section id="sec20"><h3 class="pmc_sec_title">Pharmacokinetics</h3>
<p>The mean (SD) plasma unconjugated LZP concentration–time curves following i.v. and i.m. administration are shown in <a href="#fig01" class="usa-link">Figure 1</a>. Eleven patients (six i.v. and five i.m.) were excluded from the pharmacokinetic analysis for the following reasons: three patients died within 7–14 h, whereas eight patients had fewer blood samples after 24 h to describe fully the elimination phase of LZP (<a href="#fig01" class="usa-link">Figure 1</a> and <a href="#tbl3" class="usa-link">Table 3</a>). Estimated pharmacokinetic parameters are summarized in <a href="#tbl3" class="usa-link">Table 3</a>.</p>
<figure class="fig xbox font-sm" id="fig01"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50fc/2291276/5c1f90b52293/bcp0065-0012-f1.jpg" loading="lazy" height="361" width="502" alt="Figure 1"></p>
<div class="p text-right font-secondary"><a href="figure/fig01/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Mean (SD) plasma concentration <em>vs.</em> time profile of lorazepam (LZP) following administration of a single dose (0.1 mg kg<sup>−1</sup>) of LZP either intravenously (i.v.; •, <em>n</em> = 9) or intramuscularly (i.m.; ○, <em>n</em> = 6) to children with severe malaria and convulsions. The dotted line depicts the reported minimal effective concentration (30 ng ml<sup>−1</sup>) needed for seizure control</p></figcaption></figure><section class="tw xbox font-sm" id="tbl3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Pharmacokinetic parameters of lorazepam (LZP) following administration of a single dose (0.1 mg kg<sup>−1</sup>) either intravenously (i.v.) or intramuscularly (i.m.) in children with severe malaria and convulsions</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" rowspan="1" colspan="1">Parameter</th>
<th align="left" rowspan="1" colspan="1">n</th>
<th align="left" rowspan="1" colspan="1">I.v. LZP</th>
<th align="left" rowspan="1" colspan="1">n</th>
<th align="left" rowspan="1" colspan="1">I.m. LZP</th>
<th align="left" rowspan="1" colspan="1">95% CI for the difference between the means or medians</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><strong><em>C</em><sub>max</sub> (ng ml<sup>−1</sup>)</strong></td>
<td align="right" rowspan="1" colspan="1">11</td>
<td align="right" rowspan="1" colspan="1">65.1 (47.5, 86)</td>
<td align="right" rowspan="1" colspan="1">10</td>
<td align="right" rowspan="1" colspan="1">45.3 (29.6, 66.3)</td>
<td align="left" rowspan="1" colspan="1">−43.5, 5.0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong><em>t</em><sub>max</sub> (h)*</strong></td>
<td align="right" rowspan="1" colspan="1">11</td>
<td align="right" rowspan="1" colspan="1">0. 5 (0.167–0.67)</td>
<td align="right" rowspan="1" colspan="1">10</td>
<td align="right" rowspan="1" colspan="1">0.42 (0.167–1.0)</td>
<td align="left" rowspan="1" colspan="1">−0.33, 0.17</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong><em>t</em><sub>1/2</sub> (elimination), h</strong></td>
<td align="right" rowspan="1" colspan="1">9</td>
<td align="right" rowspan="1" colspan="1">23.7 (9.8, 37.6)</td>
<td align="right" rowspan="1" colspan="1">5</td>
<td align="right" rowspan="1" colspan="1">36.9 (−1.5, 75.5)</td>
<td align="left" rowspan="1" colspan="1">−41.3, 14.9</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>AUC<sub>0–∞</sub> (ng ml<sup>−1</sup> h<sup>−1</sup>)</strong></td>
<td align="right" rowspan="1" colspan="1">9</td>
<td align="right" rowspan="1" colspan="1">2062.5 (600.6, 3771.4)</td>
<td align="right" rowspan="1" colspan="1">5</td>
<td align="right" rowspan="1" colspan="1">1843.6 (296.7, 3390.5)</td>
<td align="left" rowspan="1" colspan="1">−1267.8, 1883.0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong><em>k</em><sub><em>a</em></sub> (h<sup>−1</sup>)*</strong></td>
<td rowspan="1" colspan="1"></td>
<td align="right" rowspan="1" colspan="1">–</td>
<td align="right" rowspan="1" colspan="1">6</td>
<td align="right" rowspan="1" colspan="1">9.8 (0.033, 22.8)</td>
<td align="left" rowspan="1" colspan="1">–</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong><em>t</em><sub>1/2</sub> (absorption), h*</strong></td>
<td rowspan="1" colspan="1"></td>
<td align="right" rowspan="1" colspan="1">–</td>
<td align="right" rowspan="1" colspan="1">6</td>
<td align="right" rowspan="1" colspan="1">0.035 (0.01, 0.071)</td>
<td align="left" rowspan="1" colspan="1">–</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>CL (l h<sup>−1</sup>)</strong></td>
<td align="right" rowspan="1" colspan="1">9</td>
<td align="right" rowspan="1" colspan="1">0.64 (0.36, 0.92)</td>
<td rowspan="1" colspan="1"></td>
<td align="right" rowspan="1" colspan="1">–</td>
<td align="left" rowspan="1" colspan="1">–</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong><em>V</em><sub>C</sub> (l kg<sup>−1</sup>)</strong></td>
<td align="right" rowspan="1" colspan="1">9</td>
<td align="right" rowspan="1" colspan="1">1.67 (1.25, 2.10)</td>
<td rowspan="1" colspan="1"></td>
<td align="right" rowspan="1" colspan="1">–</td>
<td align="left" rowspan="1" colspan="1">–</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong><em>V</em><sub>ss</sub> (l kg<sup>−1</sup>)</strong></td>
<td align="right" rowspan="1" colspan="1">9</td>
<td align="right" rowspan="1" colspan="1">2.59 (1.56, 3.62)</td>
<td rowspan="1" colspan="1"></td>
<td align="right" rowspan="1" colspan="1">–</td>
<td align="left" rowspan="1" colspan="1">–</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><strong>Bioavailability (<em>F</em>)</strong></td>
<td align="right" rowspan="1" colspan="1">9</td>
<td align="right" rowspan="1" colspan="1">Assume 100%</td>
<td align="right" rowspan="1" colspan="1">6</td>
<td align="right" rowspan="1" colspan="1">89.4%</td>
<td align="left" rowspan="1" colspan="1">–</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn3"><p>Values are presented as mean (95% CI) or median (range) *.</p></div></div></section><p>Plasma concentrations of paracetamol were determined in 15 of 26 children (58%) (eight and seven children in the i.v. and i.m. groups, respectively; there was insufficient plasma volume in the remaining 11 children). Seven children (three in the i.v. and four in the i.m. group) had detectable plasma paracetamol concentrations at various times over the 72-h study period (range 1–18.6 µg ml<sup>−1</sup> and 1–33 µg ml<sup>−1</sup>, respectively). The pharmacokinetics of LZP are not affected, i.e. the values for AUC<sub>0–∞</sub> and <em>t</em><sub>1/2</sub> for children who had detectable paracetamol concentrations were within the 95% CI for the mean for the group.</p></section><section id="sec21"><h3 class="pmc_sec_title">Safety</h3>
<p>No significant adverse events occurred in any child during the study period. No local adverse reactions were detected in the i.m. injection site and no clinically significant changes in vital signs were observed during the entire study course. Two deaths occurred in the i.v. group, whereas one death occurred in the i.m. group. These children had cerebral malaria and convulsions, and remained in deep coma, and died after 7, 8 and 14 h after drug administration. Cardiorespiratory arrest not considered to be related to LZP was identified as the immediate cause of death in all these cases.</p></section></section><section id="sec22"><h2 class="pmc_sec_title">Discussion</h2>
<p>This study has shown that LZP when administered intravenously or intramuscularly is a potent, effective and safe agent in terminating acute seizures in children with SM. No published study has evaluated the relationship between plasma LZP concentrations and clinical efficacy in children with SM and convulsions. Given its favourable pharmacokinetics and potential practical advantages, we assessed the pharmacokinetics and clinical efficacy and safety of i.v. and i.m. LZP in the treatment of acute seizures in children with SM.</p>
<p>A single dose of LZP controlled the seizures in all the children studied. Of more significant clinical relevance besides its effectiveness is the fact that at the dose (0.1 mg kg<sup>−1</sup>), it appears to be safe and no significant cardiorespiratory depressant effects were noted in any of the patients. The duration of prophylaxis of seizures following LZP was at least 72 h in about 81% (21/26) of the children treated, which is in agreement with previous reports [<a href="#b17" class="usa-link" aria-describedby="b17">17</a>]. This prolonged duration of action of LZP may prevent frequent or continuous drug administration.</p>
<p>The clinical pharmacology and pharmacokinetics of LZP in African children with SM and convulsions are unknown. Plasma LZP concentrations were maintained above the reported minimal effective concentrations for seizure control (30 ng ml<sup>−1</sup>) for at least 8 h following both i.v. and i.m. administration. These observations are in accord with previous studies [<a href="#b12" class="usa-link" aria-describedby="b12">12</a>, <a href="#b44" class="usa-link" aria-describedby="b44">44</a>, <a href="#b45" class="usa-link" aria-describedby="b45">45</a>]. In clinical practice, this implies that in most patients administered LZP, it would not be necessary to give repeated injections or continuous infusions to maintain prolonged seizure control. LZP may be preferable to DZ or MDZ because it produces more sustained seizure control and has a lower incidence of respiratory depression. The mean clearance, volume of distribution and elimination half-life values estimated in the present study after i.v. administration are comparable with values previously reported in children [<a href="#b22" class="usa-link" aria-describedby="b22">22</a>, <a href="#b46" class="usa-link" aria-describedby="b46">46</a>, <a href="#b47" class="usa-link" aria-describedby="b47">47</a>]. The pharmacokinetic parameters of LZP are reported to exhibit a considerable degree of interindividual variability, which is expected in critically ill patients with large differences in patient characteristics, pathophysiology and duration of therapy [<a href="#b48" class="usa-link" aria-describedby="b48">48</a>].</p>
<section id="sec23"><h3 class="pmc_sec_title">Regimen</h3>
<p>The recommended i.v. dose of LZP for SE is 0.1 mg kg<sup>−1</sup> (maximum dose 4 mg) administered at a rate of 2 mg min<sup>−1</sup>; the dose can be repeated after 10–15 min if seizures do not stop or recur [<a href="#b17" class="usa-link" aria-describedby="b17">17</a>, <a href="#b22" class="usa-link" aria-describedby="b22">22</a>–<a href="#b24" class="usa-link" aria-describedby="b24">24</a>]. In a retrospective study comparing i.v. LZP with i.v. DZ in the treatment of SE in children (age 2 weeks to 18 years), an initial dose of LZP (0.05 mg kg<sup>−1</sup>) controlled only 23% of SE, but a mean dose of 0.11 mg kg<sup>−1</sup> (range 0.03–0.22) was effective in controlling SE [<a href="#b49" class="usa-link" aria-describedby="b49">49</a>]. A dose of 0.05–0.1 mg kg<sup>−1</sup> (repeated once) effectively controlled acute epileptic seizures and SE in 76% of children [<a href="#b23" class="usa-link" aria-describedby="b23">23</a>]. The dose used in the present study (0.1 mg kg<sup>−1</sup>) is within the suggested range and is in agreement with the suggestion that an initial dose of LZP of 0.1 mg kg<sup>−1</sup> (instead of 0.05 mg kg<sup>−1</sup>) should be administered to control SE [<a href="#b22" class="usa-link" aria-describedby="b22">22</a>].</p></section><section id="sec24"><h3 class="pmc_sec_title">Efficacy</h3>
<p>The overall success rate of 81% (21 of 26) of the children treated with LZP in this study is comparable to previously reported rates (65–100%) [<a href="#b12" class="usa-link" aria-describedby="b12">12</a>, <a href="#b14" class="usa-link" aria-describedby="b14">14</a>, <a href="#b15" class="usa-link" aria-describedby="b15">15</a>, <a href="#b17" class="usa-link" aria-describedby="b17">17</a>, <a href="#b19" class="usa-link" aria-describedby="b19">19</a>, <a href="#b20" class="usa-link" aria-describedby="b20">20</a>, <a href="#b22" class="usa-link" aria-describedby="b22">22</a>, <a href="#b23" class="usa-link" aria-describedby="b23">23</a>, <a href="#b49" class="usa-link" aria-describedby="b49">49</a>]. In children and adolescents aged 8.7 years (range 2–18), a median cumulative dose of 2 mg of LZP effectively terminated seizures in 25 of 31 patients (81%) within a median time of 10 min; the seizures stopped within 10 and 20 min in 60% and 84% of the patients, respectively [<a href="#b17" class="usa-link" aria-describedby="b17">17</a>]. Moreover, LZP was more effective in terminating generalized convulsive SE; 92% of the patients had their seizures controlled within a median time of 6 min [<a href="#b17" class="usa-link" aria-describedby="b17">17</a>].</p>
<p>The median latency period of LZP in the present study (10 min) was longer than that reported in previous studies (&lt;3 min) in children [<a href="#b22" class="usa-link" aria-describedby="b22">22</a>, <a href="#b23" class="usa-link" aria-describedby="b23">23</a>] or adults [<a href="#b14" class="usa-link" aria-describedby="b14">14</a>] with SE who were successfully treated with LZP. With the use of a median dose of 0.1 mg kg<sup>−1</sup> in children &lt;1 year old, and successively lower doses per body weight in older children, other investigators found that LZP stopped seizures in 75% of the patients within 10 min [<a href="#b22" class="usa-link" aria-describedby="b22">22</a>]. It is possible that the latency period of LZP in this study was longer than some reported in the literature because of the underlying malaria pathology. Severe malaria in children is a complex syndrome, and the cause of seizures in children with falciparum malaria is not clear, but may be due to fever or some specific effect of <em>Plasmodium falciparum</em> to the brain [<a href="#b50" class="usa-link" aria-describedby="b50">50</a>]. This group might be considered to be more difficult to control, but the success of i.v. or i.m. LZP in our study was satisfactory. In five children (one in i.v. group and four in i.m. group), seizures continued beyond 15 min (range 16–27); in such situations, the dose of LZP can be repeated [<a href="#b23" class="usa-link" aria-describedby="b23">23</a>, <a href="#b24" class="usa-link" aria-describedby="b24">24</a>].</p></section><section id="sec25"><h3 class="pmc_sec_title">Safety</h3>
<p>In the present study, none of the children had any episode of respiratory depression or arrest. Previous studies have reported respiratory depression rates ranging from 0% to 25% in both children [<a href="#b15" class="usa-link" aria-describedby="b15">15</a>, <a href="#b22" class="usa-link" aria-describedby="b22">22</a>, <a href="#b23" class="usa-link" aria-describedby="b23">23</a>, <a href="#b49" class="usa-link" aria-describedby="b49">49</a>] and adults [<a href="#b14" class="usa-link" aria-describedby="b14">14</a>] treated with LZP. Children aged &lt;2 years [<a href="#b49" class="usa-link" aria-describedby="b49">49</a>] and older patients [<a href="#b14" class="usa-link" aria-describedby="b14">14</a>] are significantly more likely to experience respiratory depression or arrest than older children. Transient respiratory arrest has been reported in a single adult patient following administration of a single i.v. dose (4 mg) of LZP [<a href="#b12" class="usa-link" aria-describedby="b12">12</a>]. No clinical signs of respiratory depression were noted, but detailed measurements were not performed and only a small number of subjects was studied.</p>
<p>Three deaths occurred among the children who were enrolled in the present study. However, none died immediately after LZP was administered; they died at least 7 h following LZP administration. These children had cerebral malaria and convulsions and remained in deep coma throughout the study period. In addition, one child had hypoglycaemia in addition, while another had anaemia and was given blood transfusion. The LZP <em>C</em><sub>max</sub> (range 27–59 ng ml<sup>−1</sup>) and <em>t</em><sub>max</sub> (range 0.167–1.0 h) values in these three subjects were within the 95% CIs for the group. Although cardiorespiratory arrest was identified as the immediate cause of death in all these cases, it is unlikely that LZP could have played a major role, since the results from the present study have shown that LZP is not associated with any significant respiratory depressant effects. It is possible that these children were more severely ill than the survivors.</p></section><section id="sec26"><h3 class="pmc_sec_title">Potential drug interactions</h3>
<p>The major route of LZP elimination is direct conjugation to its glucuronide conjugate, which has little intrinsic pharmacological activity [<a href="#b51" class="usa-link" aria-describedby="b51">51</a>]. An important and clinically relevant issue in treatment of children with acute seizures and severe disease is the potential drug interaction with commonly concurrently administered drugs. Of relevance in this study are paracetamol and chloramphenicol, which share the same conjugation pathway with LZP. At therapeutic doses, paracetamol is primarily metabolized via glucuronidation and sulphation by UDP glucuronosyl-transferases and sulpho-transferases, respectively [<a href="#b52" class="usa-link" aria-describedby="b52">52</a>]. Few clinically significant drug interactions involving paracetamol have been documented. At present, no published data on the interaction between paracetamol and LZP in humans are available. The results of the present study suggest that there was no interaction between LZP and paracetamol.</p>
<p>Chloramphenicol undergoes a wide variety of metabolic biotransformations in the liver, including conjugation, acetylation, hydrolysis and oxidation. In the present study, plasma concentrations of chloramphenicol were not determined due to the volume-limited samples that could be taken from these patients. Thus, it is difficult to assess whether concurrent administration of chloramphenicol had any clinically significant effects on the pharmacokinetics of LZP in this group.</p>
<p>In the emergency setting, it is often important to administer LZP via the i.v. route for rapid onset of action and assured dose bioavailability. The need to treat acute convulsions promptly when i.v. access is unavailable requires consideration of administration of anticonvulsants by alternative routes. Pharmacokinetic data and a long duration of action (2–72 h) of LZP indicate that it is a suitable alternative [<a href="#b12" class="usa-link" aria-describedby="b12">12</a>]. The results from the present study show that i.m. LZP is at least as effective as i.v. LZP and may therefore be useful for acute treatment and prevention of recurrence of convulsions in children in less well equipped and staffed areas, especially in most rural parts in Africa. LZP has been administered rectally in humans when i.v. access was limited or difficult [<a href="#b23" class="usa-link" aria-describedby="b23">23</a>], but it has a slow absorption rate in humans [<a href="#b53" class="usa-link" aria-describedby="b53">53</a>]. Midazolam (MDZ) has also been used for the emergency treatment of acute seizures in children. Buccal MDZ is at least as effective as rectal DZ in terminating seizures, and it might also be easier to use and more socially acceptable to the caregivers than the rectal route [<a href="#b54" class="usa-link" aria-describedby="b54">54</a>, <a href="#b55" class="usa-link" aria-describedby="b55">55</a>].</p></section><section id="sec27"><h3 class="pmc_sec_title">Limitations of the study</h3>
<p>There were some methodological difficulties and, consequently, potential weaknesses and inherent limitations associated with this study. First, the study was open and nonrandomized, and patients were allocated sequentially to the treatment groups. The selection of patients could have been subject to bias. It is possible that some patients' seizures stopped spontaneously and not because of treatment with LZP. We attempted to minimize this possibility by requiring ongoing seizures to last for at least 5 min before administering LZP. In clinical practice, most physicians would initiate anticonvulsant therapy after 5–10 min of continuous motor seizures. However, this is a possible confounding factor in any clinical study assessing the efficacy of anticonvulsants. Second, recurrence of convulsions was noted only in the i.v. group. This could have been due to the fact that children in the i.v. group had convulsions that were more prolonged and thus more difficult to treat. Third, this study was conducted in a pragmatic way within a clinical setting in a typical referral hospital in a resource-poor country, with limited healthcare facilities. Thus, it was not possible to collect additional data (e.g. blood gases, oxygen saturation, blood glucose), which would have been useful in the interpretation of the results on outcome. However, this reflects the reality of what could be expected in such settings, where the drug is likely to be used. Diazepam is routinely used in this setting under similar conditions; it can be assumed (although cautiously) that LZP (which is less likely to cause respiratory depression) would not cause major problems. Finally, sample size calculations were not performed, and the number of patients included in each group was small. Thus, it is difficult to assess whether the study was sufficiently powered to detect any true differences in rates of efficacy and respiratory depression between the two routes of administration.</p></section></section><section id="sec28"><h2 class="pmc_sec_title">Conclusion</h2>
<p>The results of this study have shown that LZP is effective in termination of acute seizures in children with SM. LZP appears to be well absorbed following i.m. administration, which has an elimination profile comparable to i.v. administration. No significant adverse effects were noted with either of the two administration routes. I.m LZP may be particularly useful as a first-line agent in management of acute convulsions in children in whom i.v. access may be difficult. A randomized study comparing the clinical efficacy of LZP with DZ or MDZ in terminating convulsions associated with SM in children is warranted to substantiate these preliminary results.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>We thank all the clinical, nursing and laboratory personnel and fieldworkers at the paediatric ward of the New Nyanza Provincial General Hospital, Kisumu, for their valuable support. We are equally grateful to all the children and their parents/guardians who participated. We thank Professor Kevin Marsh and Dr Norbert Peshu [both of the KEMRI/Wellcome Trust Research Programme, Centre for Geographic Medicine Research (Coast), Kilifi], for their support. G.O.K. was supported by a Research Capability Strengthening Grant from WHO (TDR/MIM grant no. 980074 and A50071). S.N.M. was a PhD student in clinical pharmacology supported by The Wellcome Trust of Great Britain. C.R.J.C.N. is a Wellcome Trust Senior Clinical Research Fellow (grant no. 070114/Z/02/Z). This paper is published with permission of the Director of the Kenya Medical Research Institute (KEMRI).</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="b1">
<span class="label">1.</span><cite>Crawley J, Smith S, Kirkham F, Muthinji P, Waruiru C, Marsh K. Seizures and status epilepticus in childhood cerebral malaria. Q J Med. 1996;89:591–7. doi: 10.1093/qjmed/89.8.591.</cite> [<a href="https://doi.org/10.1093/qjmed/89.8.591" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8935480/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Q%20J%20Med&amp;title=Seizures%20and%20status%20epilepticus%20in%20childhood%20cerebral%20malaria&amp;author=J%20Crawley&amp;author=S%20Smith&amp;author=F%20Kirkham&amp;author=P%20Muthinji&amp;author=C%20Waruiru&amp;volume=89&amp;publication_year=1996&amp;pages=591-7&amp;pmid=8935480&amp;doi=10.1093/qjmed/89.8.591&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b2">
<span class="label">2.</span><cite>Crawley J, Waruiru C, Mithwani S, Mwangi I, Watkins W, Ouma D, Winstanley P, Peto T, Marsh K. Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study. Lancet. 2000;355:701–6. doi: 10.1016/S0140-6736(99)07148-2.</cite> [<a href="https://doi.org/10.1016/S0140-6736(99)07148-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10703801/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Effect%20of%20phenobarbital%20on%20seizure%20frequency%20and%20mortality%20in%20childhood%20cerebral%20malaria:%20a%20randomised,%20controlled%20intervention%20study&amp;author=J%20Crawley&amp;author=C%20Waruiru&amp;author=S%20Mithwani&amp;author=I%20Mwangi&amp;author=W%20Watkins&amp;volume=355&amp;publication_year=2000&amp;pages=701-6&amp;pmid=10703801&amp;doi=10.1016/S0140-6736(99)07148-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b3">
<span class="label">3.</span><cite>Waruiru CM, Newton CR, Forster D, New L, Winstanley P, Mwangi I, Marsh V, Winstanley M, Snow RW, Marsh K. Epileptic seizures and malaria in Kenyan children. Trans R Soc Trop Med Hyg. 1996;90:152–5. doi: 10.1016/s0035-9203(96)90120-0.</cite> [<a href="https://doi.org/10.1016/s0035-9203(96)90120-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8761576/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trans%20R%20Soc%20Trop%20Med%20Hyg&amp;title=Epileptic%20seizures%20and%20malaria%20in%20Kenyan%20children&amp;author=CM%20Waruiru&amp;author=CR%20Newton&amp;author=D%20Forster&amp;author=L%20New&amp;author=P%20Winstanley&amp;volume=90&amp;publication_year=1996&amp;pages=152-5&amp;pmid=8761576&amp;doi=10.1016/s0035-9203(96)90120-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b4">
<span class="label">4.</span><cite>Waller D, Krishna S, Crawley J, Miller K, Nosten F, Chapman D, ter Kuile FO, Craddock C, Berry C, Holloway PA, Brewster D, Greenwood BM, White NJ. Clinical features and outcome of severe malaria in Gambian children. Clin Infect Dis. 1995;21:577–87. doi: 10.1093/clinids/21.3.577.</cite> [<a href="https://doi.org/10.1093/clinids/21.3.577" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8527547/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Infect%20Dis&amp;title=Clinical%20features%20and%20outcome%20of%20severe%20malaria%20in%20Gambian%20children&amp;author=D%20Waller&amp;author=S%20Krishna&amp;author=J%20Crawley&amp;author=K%20Miller&amp;author=F%20Nosten&amp;volume=21&amp;publication_year=1995&amp;pages=577-87&amp;pmid=8527547&amp;doi=10.1093/clinids/21.3.577&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b5">
<span class="label">5.</span><cite>Holding PA, Stevenson J, Peshu N, Marsh K. Cognitive sequelae of severe malaria with impaired consciousness. Trans R Soc Trop Med Hyg. 1999;93:529–34. doi: 10.1016/s0035-9203(99)90368-1.</cite> [<a href="https://doi.org/10.1016/s0035-9203(99)90368-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10696414/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trans%20R%20Soc%20Trop%20Med%20Hyg&amp;title=Cognitive%20sequelae%20of%20severe%20malaria%20with%20impaired%20consciousness&amp;author=PA%20Holding&amp;author=J%20Stevenson&amp;author=N%20Peshu&amp;author=K%20Marsh&amp;volume=93&amp;publication_year=1999&amp;pages=529-34&amp;pmid=10696414&amp;doi=10.1016/s0035-9203(99)90368-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b6">
<span class="label">6.</span><cite>Newton CR, Krishna S. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther. 1998;79:1–53. doi: 10.1016/s0163-7258(98)00008-4.</cite> [<a href="https://doi.org/10.1016/s0163-7258(98)00008-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9719344/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol%20Ther&amp;title=Severe%20falciparum%20malaria%20in%20children:%20current%20understanding%20of%20pathophysiology%20and%20supportive%20treatment&amp;author=CR%20Newton&amp;author=S%20Krishna&amp;volume=79&amp;publication_year=1998&amp;pages=1-53&amp;pmid=9719344&amp;doi=10.1016/s0163-7258(98)00008-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b7">
<span class="label">7.</span><cite>Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med. 1998;338:970–6. doi: 10.1056/NEJM199804023381407.</cite> [<a href="https://doi.org/10.1056/NEJM199804023381407" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9521986/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Status%20epilepticus&amp;author=DH%20Lowenstein&amp;author=BK%20Alldredge&amp;volume=338&amp;publication_year=1998&amp;pages=970-6&amp;pmid=9521986&amp;doi=10.1056/NEJM199804023381407&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b8">
<span class="label">8.</span><cite>Shorvon S.  Status Epilepticus: Its Clinical Features and Treatment in Childhood and Adults. Cambridge: Cambridge University Press; 1994. </cite> [<a href="https://scholar.google.com/scholar_lookup?title=Status%20Epilepticus:%20Its%20Clinical%20Features%20and%20Treatment%20in%20Childhood%20and%20Adults&amp;author=S%20Shorvon&amp;publication_year=1994&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b9">
<span class="label">9.</span><cite>Ogutu BR, Newton CR, Crawley J, Muchohi SN, Otieno GO, Edwards G, Marsh K, Kokwaro GO. Pharmacokinetics and anticonvulsant effects of diazepam in children with severe falciparum malaria and convulsions. Br J Clin Pharmacol. 2002;53:49–57. doi: 10.1046/j.0306-5251.2001.01529.x.</cite> [<a href="https://doi.org/10.1046/j.0306-5251.2001.01529.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1874558/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11849195/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Clin%20Pharmacol&amp;title=Pharmacokinetics%20and%20anticonvulsant%20effects%20of%20diazepam%20in%20children%20with%20severe%20falciparum%20malaria%20and%20convulsions&amp;author=BR%20Ogutu&amp;author=CR%20Newton&amp;author=J%20Crawley&amp;author=SN%20Muchohi&amp;author=GO%20Otieno&amp;volume=53&amp;publication_year=2002&amp;pages=49-57&amp;pmid=11849195&amp;doi=10.1046/j.0306-5251.2001.01529.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b10">
<span class="label">10.</span><cite>Norris E, Marzouk O, Nunn A, McIntyre J, Choonara I. Respiratory depression in children receiving diazepam for acute seizures: a prospective study. Dev Med Child Neurol. 1999;41:340–3. doi: 10.1017/s0012162299000742.</cite> [<a href="https://doi.org/10.1017/s0012162299000742" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10378761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dev%20Med%20Child%20Neurol&amp;title=Respiratory%20depression%20in%20children%20receiving%20diazepam%20for%20acute%20seizures:%20a%20prospective%20study&amp;author=E%20Norris&amp;author=O%20Marzouk&amp;author=A%20Nunn&amp;author=J%20McIntyre&amp;author=I%20Choonara&amp;volume=41&amp;publication_year=1999&amp;pages=340-3&amp;pmid=10378761&amp;doi=10.1017/s0012162299000742&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b11">
<span class="label">11.</span><cite>Dundee JW, Gamble JA, Assaf RA. Plasma-diazepam levels following intramuscular injection by nurses and doctors (Letter) Lancet. 1974;2:1461. doi: 10.1016/s0140-6736(74)90130-5.</cite> [<a href="https://doi.org/10.1016/s0140-6736(74)90130-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/4140385/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Plasma-diazepam%20levels%20following%20intramuscular%20injection%20by%20nurses%20and%20doctors%20(Letter)&amp;author=JW%20Dundee&amp;author=JA%20Gamble&amp;author=RA%20Assaf&amp;volume=2&amp;publication_year=1974&amp;pages=1461&amp;pmid=4140385&amp;doi=10.1016/s0140-6736(74)90130-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b12">
<span class="label">12.</span><cite>Walker JE, Homan RW, Vasko MR, Crawford IL, Bell RD, Tasker WG. Lorazepam in status epilepticus. Ann Neurol. 1979;6:207–13. doi: 10.1002/ana.410060305.</cite> [<a href="https://doi.org/10.1002/ana.410060305" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/43112/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Neurol&amp;title=Lorazepam%20in%20status%20epilepticus&amp;author=JE%20Walker&amp;author=RW%20Homan&amp;author=MR%20Vasko&amp;author=IL%20Crawford&amp;author=RD%20Bell&amp;volume=6&amp;publication_year=1979&amp;pages=207-13&amp;pmid=43112&amp;doi=10.1002/ana.410060305&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b13">
<span class="label">13.</span><cite>Homan R, Walker J.  Clinical studies of lorazepam in status epilepticus. In: Delgado-Escueta A, Wastterlain CG, Treiman D, editors. Advances in Neurology: Status Epilepticus. New York: Raven Press; 1993. pp. 493–8.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/6131587/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?title=Advances%20in%20Neurology:%20Status%20Epilepticus&amp;author=R%20Homan&amp;author=J%20Walker&amp;publication_year=1993&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b14">
<span class="label">14.</span><cite>Leppik IE, Derivan AT, Homan RW, Walker J, Ramsay RE, Patrick B. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA. 1983;249:1452–4.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/6131148/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Double-blind%20study%20of%20lorazepam%20and%20diazepam%20in%20status%20epilepticus&amp;author=IE%20Leppik&amp;author=AT%20Derivan&amp;author=RW%20Homan&amp;author=J%20Walker&amp;author=RE%20Ramsay&amp;volume=249&amp;publication_year=1983&amp;pages=1452-4&amp;pmid=6131148&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b15">
<span class="label">15.</span><cite>Levy RJ, Krall RL. Treatment of status epilepticus with lorazepam. Arch Neurol. 1984;41:605–11. doi: 10.1001/archneur.1984.04210080013006.</cite> [<a href="https://doi.org/10.1001/archneur.1984.04210080013006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6721734/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch%20Neurol&amp;title=Treatment%20of%20status%20epilepticus%20with%20lorazepam&amp;author=RJ%20Levy&amp;author=RL%20Krall&amp;volume=41&amp;publication_year=1984&amp;pages=605-11&amp;pmid=6721734&amp;doi=10.1001/archneur.1984.04210080013006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b16">
<span class="label">16.</span><cite>Walker JE, Homan RW, Crawford IL. Lorazepam: a controlled trial in patients with intractable partial complex seizures. Epilepsia. 1984;25:464–6. doi: 10.1111/j.1528-1157.1984.tb03444.x.</cite> [<a href="https://doi.org/10.1111/j.1528-1157.1984.tb03444.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6378615/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Epilepsia&amp;title=Lorazepam:%20a%20controlled%20trial%20in%20patients%20with%20intractable%20partial%20complex%20seizures&amp;author=JE%20Walker&amp;author=RW%20Homan&amp;author=IL%20Crawford&amp;volume=25&amp;publication_year=1984&amp;pages=464-6&amp;pmid=6378615&amp;doi=10.1111/j.1528-1157.1984.tb03444.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b17">
<span class="label">17.</span><cite>Lacey DJ, Singer WD, Horwitz SJ, Gilmore H. Lorazepam therapy of status epilepticus in children and adolescents. J Pediatr. 1986;108:771–4. doi: 10.1016/s0022-3476(86)81065-4.</cite> [<a href="https://doi.org/10.1016/s0022-3476(86)81065-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3084747/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pediatr&amp;title=Lorazepam%20therapy%20of%20status%20epilepticus%20in%20children%20and%20adolescents&amp;author=DJ%20Lacey&amp;author=WD%20Singer&amp;author=SJ%20Horwitz&amp;author=H%20Gilmore&amp;volume=108&amp;publication_year=1986&amp;pages=771-4&amp;pmid=3084747&amp;doi=10.1016/s0022-3476(86)81065-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b18">
<span class="label">18.</span><cite>Deshmukh A, Wittert W, Schnitzler E, Mangurten HH. Lorazepam in the treatment of refractory neonatal seizures. A pilot study. Am J Dis Child. 1986;140:1042–4. doi: 10.1001/archpedi.1986.02140240088032.</cite> [<a href="https://doi.org/10.1001/archpedi.1986.02140240088032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3752014/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Dis%20Child&amp;title=Lorazepam%20in%20the%20treatment%20of%20refractory%20neonatal%20seizures.%20A%20pilot%20study&amp;author=A%20Deshmukh&amp;author=W%20Wittert&amp;author=E%20Schnitzler&amp;author=HH%20Mangurten&amp;volume=140&amp;publication_year=1986&amp;pages=1042-4&amp;pmid=3752014&amp;doi=10.1001/archpedi.1986.02140240088032&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b19">
<span class="label">19.</span><cite>Ahmad S, Ellis JC, Kamwendo H, Molyneux E. Efficacy and safety of intranasal lorazepam versus intramuscular paraldehyde for protracted convulsions in children: an open randomised trial. Lancet. 2006;367:1591–7. doi: 10.1016/S0140-6736(06)68696-0.</cite> [<a href="https://doi.org/10.1016/S0140-6736(06)68696-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16698412/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Efficacy%20and%20safety%20of%20intranasal%20lorazepam%20versus%20intramuscular%20paraldehyde%20for%20protracted%20convulsions%20in%20children:%20an%20open%20randomised%20trial&amp;author=S%20Ahmad&amp;author=JC%20Ellis&amp;author=H%20Kamwendo&amp;author=E%20Molyneux&amp;volume=367&amp;publication_year=2006&amp;pages=1591-7&amp;pmid=16698412&amp;doi=10.1016/S0140-6736(06)68696-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b20">
<span class="label">20.</span><cite>Qureshi A, Wassmer E, Davies P, Berry K, Whitehouse WP. Comparative audit of intravenous lorazepam and diazepam in the emergency treatment of convulsive status epilepticus in children. Seizure. 2002;11:141–4. doi: 10.1053/seiz.2001.0635.</cite> [<a href="https://doi.org/10.1053/seiz.2001.0635" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12018955/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Seizure&amp;title=Comparative%20audit%20of%20intravenous%20lorazepam%20and%20diazepam%20in%20the%20emergency%20treatment%20of%20convulsive%20status%20epilepticus%20in%20children&amp;author=A%20Qureshi&amp;author=E%20Wassmer&amp;author=P%20Davies&amp;author=K%20Berry&amp;author=WP%20Whitehouse&amp;volume=11&amp;publication_year=2002&amp;pages=141-4&amp;pmid=12018955&amp;doi=10.1053/seiz.2001.0635&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b21">
<span class="label">21.</span><cite>Alldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, Gottwald MD, O'Neil N, Neuhaus JM, Segal MR, Lowenstein DH. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001;345:631–7. doi: 10.1056/NEJMoa002141.</cite> [<a href="https://doi.org/10.1056/NEJMoa002141" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11547716/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=A%20comparison%20of%20lorazepam,%20diazepam,%20and%20placebo%20for%20the%20treatment%20of%20out-of-hospital%20status%20epilepticus&amp;author=BK%20Alldredge&amp;author=AM%20Gelb&amp;author=SM%20Isaacs&amp;author=MD%20Corry&amp;author=F%20Allen&amp;volume=345&amp;publication_year=2001&amp;pages=631-7&amp;pmid=11547716&amp;doi=10.1056/NEJMoa002141&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b22">
<span class="label">22.</span><cite>Crawford TO, Mitchell WG, Snodgrass SR. Lorazepam in childhood status epilepticus and serial seizures: effectiveness and tachyphylaxis. Neurology. 1987;37:190–5. doi: 10.1212/wnl.37.2.190.</cite> [<a href="https://doi.org/10.1212/wnl.37.2.190" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3808299/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Lorazepam%20in%20childhood%20status%20epilepticus%20and%20serial%20seizures:%20effectiveness%20and%20tachyphylaxis&amp;author=TO%20Crawford&amp;author=WG%20Mitchell&amp;author=SR%20Snodgrass&amp;volume=37&amp;publication_year=1987&amp;pages=190-5&amp;pmid=3808299&amp;doi=10.1212/wnl.37.2.190&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b23">
<span class="label">23.</span><cite>Appleton R, Sweeney A, Choonara I, Robson J, Molyneux E. Lorazepam versus diazepam in the acute treatment of epileptic seizures and status epilepticus. Dev Med Child Neurol. 1995;37:682–8. doi: 10.1111/j.1469-8749.1995.tb15014.x.</cite> [<a href="https://doi.org/10.1111/j.1469-8749.1995.tb15014.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7672465/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dev%20Med%20Child%20Neurol&amp;title=Lorazepam%20versus%20diazepam%20in%20the%20acute%20treatment%20of%20epileptic%20seizures%20and%20status%20epilepticus&amp;author=R%20Appleton&amp;author=A%20Sweeney&amp;author=I%20Choonara&amp;author=J%20Robson&amp;author=E%20Molyneux&amp;volume=37&amp;publication_year=1995&amp;pages=682-8&amp;pmid=7672465&amp;doi=10.1111/j.1469-8749.1995.tb15014.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b24">
<span class="label">24.</span><cite>Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, Handforth A, Faught E, Calabrese VP, Uthman BM, Ramsay RE, Mamdani MB. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339:792–8. doi: 10.1056/NEJM199809173391202.</cite> [<a href="https://doi.org/10.1056/NEJM199809173391202" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9738086/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=A%20comparison%20of%20four%20treatments%20for%20generalized%20convulsive%20status%20epilepticus.%20Veterans%20Affairs%20Status%20Epilepticus%20Cooperative%20Study%20Group&amp;author=DM%20Treiman&amp;author=PD%20Meyers&amp;author=NY%20Walton&amp;author=JF%20Collins&amp;author=C%20Colling&amp;volume=339&amp;publication_year=1998&amp;pages=792-8&amp;pmid=9738086&amp;doi=10.1056/NEJM199809173391202&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b25">
<span class="label">25.</span><cite>Cronin CM. Neurotoxicity of lorazepam in a premature infant. Pediatrics. 1992;89:1129–30.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/1594363/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatrics&amp;title=Neurotoxicity%20of%20lorazepam%20in%20a%20premature%20infant&amp;author=CM%20Cronin&amp;volume=89&amp;publication_year=1992&amp;pages=1129-30&amp;pmid=1594363&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b26">
<span class="label">26.</span><cite>Vlachos P, Kentarchou P, Aloupogiannis G. Lorazepam poisoning. Toxicol Lett. 1978;2:109–10.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Toxicol%20Lett&amp;title=Lorazepam%20poisoning&amp;author=P%20Vlachos&amp;author=P%20Kentarchou&amp;author=G%20Aloupogiannis&amp;volume=2&amp;publication_year=1978&amp;pages=109-10&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b27">
<span class="label">27.</span><cite>English M, Sauerwein R, Waruiru C, Mosobo M, Obiero J, Lowe B, Marsh K. Acidosis in severe childhood malaria. Q J Med. 1997;90:263–70. doi: 10.1093/qjmed/90.4.263.</cite> [<a href="https://doi.org/10.1093/qjmed/90.4.263" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9307760/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Q%20J%20Med&amp;title=Acidosis%20in%20severe%20childhood%20malaria&amp;author=M%20English&amp;author=R%20Sauerwein&amp;author=C%20Waruiru&amp;author=M%20Mosobo&amp;author=J%20Obiero&amp;volume=90&amp;publication_year=1997&amp;pages=263-70&amp;pmid=9307760&amp;doi=10.1093/qjmed/90.4.263&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b28">
<span class="label">28.</span><cite>Newton CR, Kirkham FJ, Winstanley PA, Pasvol G, Peshu N, Warrell DA, Marsh K. Intracranial pressure in African children with cerebral malaria. Lancet. 1991;337:573–6. doi: 10.1016/0140-6736(91)91638-b.</cite> [<a href="https://doi.org/10.1016/0140-6736(91)91638-b" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1671941/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Intracranial%20pressure%20in%20African%20children%20with%20cerebral%20malaria&amp;author=CR%20Newton&amp;author=FJ%20Kirkham&amp;author=PA%20Winstanley&amp;author=G%20Pasvol&amp;author=N%20Peshu&amp;volume=337&amp;publication_year=1991&amp;pages=573-6&amp;pmid=1671941&amp;doi=10.1016/0140-6736(91)91638-b&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b29">
<span class="label">29.</span><cite>World Health Organization Communicable Diseases Cluster. Severe falciparum malaria. Trans R Soc Trop Med Hyg. 2000;94(Suppl. 1):S1–90.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/11103309/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trans%20R%20Soc%20Trop%20Med%20Hyg&amp;title=Severe%20falciparum%20malaria&amp;volume=94&amp;issue=Suppl.%201&amp;publication_year=2000&amp;pages=S1-90&amp;pmid=11103309&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b30">
<span class="label">30.</span><cite>Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, Marsh V, Newton C, Winstanley P, Warn P, Peshu N, Pasvol G, Snow RW. Indicators of life-threatening malaria in African children. N Engl J Med. 1995;332:1399–404. doi: 10.1056/NEJM199505253322102.</cite> [<a href="https://doi.org/10.1056/NEJM199505253322102" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7723795/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Indicators%20of%20life-threatening%20malaria%20in%20African%20children&amp;author=K%20Marsh&amp;author=D%20Forster&amp;author=C%20Waruiru&amp;author=I%20Mwangi&amp;author=M%20Winstanley&amp;volume=332&amp;publication_year=1995&amp;pages=1399-404&amp;pmid=7723795&amp;doi=10.1056/NEJM199505253322102&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b31">
<span class="label">31.</span><cite>Winstanley PA, Mberu EK, Watkins WM, Murphy SA, Lowe B, Marsh K. Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: unbound quinine concentrations following a simple loading dose regimen. Trans R Soc Trop Med Hyg. 1994;88:577–80. doi: 10.1016/0035-9203(94)90170-8.</cite> [<a href="https://doi.org/10.1016/0035-9203(94)90170-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7992345/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trans%20R%20Soc%20Trop%20Med%20Hyg&amp;title=Towards%20optimal%20regimens%20of%20parenteral%20quinine%20for%20young%20African%20children%20with%20cerebral%20malaria:%20unbound%20quinine%20concentrations%20following%20a%20simple%20loading%20dose%20regimen&amp;author=PA%20Winstanley&amp;author=EK%20Mberu&amp;author=WM%20Watkins&amp;author=SA%20Murphy&amp;author=B%20Lowe&amp;volume=88&amp;publication_year=1994&amp;pages=577-80&amp;pmid=7992345&amp;doi=10.1016/0035-9203(94)90170-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b32">
<span class="label">32.</span><cite>English M, Waruiru C, Marsh K. Transfusion for respiratory distress in life-threatening childhood malaria. Am J Trop Med Hyg. 1996;55:525–30. doi: 10.4269/ajtmh.1996.55.525.</cite> [<a href="https://doi.org/10.4269/ajtmh.1996.55.525" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8940985/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Trop%20Med%20Hyg&amp;title=Transfusion%20for%20respiratory%20distress%20in%20life-threatening%20childhood%20malaria&amp;author=M%20English&amp;author=C%20Waruiru&amp;author=K%20Marsh&amp;volume=55&amp;publication_year=1996&amp;pages=525-30&amp;pmid=8940985&amp;doi=10.4269/ajtmh.1996.55.525&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b33">
<span class="label">33.</span><cite>Newton CR, Marsh K, Peshu N, Mwangi I. Blood transfusions for severe anaemia in African children. Lancet. 1992;340:917–8.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/1357332/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Blood%20transfusions%20for%20severe%20anaemia%20in%20African%20children&amp;author=CR%20Newton&amp;author=K%20Marsh&amp;author=N%20Peshu&amp;author=I%20Mwangi&amp;volume=340&amp;publication_year=1992&amp;pages=917-8&amp;pmid=1357332&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b34">
<span class="label">34.</span><cite>Kokwaro GO, Muchohi SN, Ogutu BR, Newton CR. Chloramphenicol pharmacokinetics in African children with severe malaria. J Trop Pediatr. 2006;52:239–43. doi: 10.1093/tropej/fmi082.</cite> [<a href="https://doi.org/10.1093/tropej/fmi082" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16126805/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Trop%20Pediatr&amp;title=Chloramphenicol%20pharmacokinetics%20in%20African%20children%20with%20severe%20malaria&amp;author=GO%20Kokwaro&amp;author=SN%20Muchohi&amp;author=BR%20Ogutu&amp;author=CR%20Newton&amp;volume=52&amp;publication_year=2006&amp;pages=239-43&amp;pmid=16126805&amp;doi=10.1093/tropej/fmi082&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b35">
<span class="label">35.</span><cite>Berkley J, Mwarumba S, Bramham K, Lowe B, Marsh K. Bacteraemia complicating severe malaria in children. Trans R Soc Trop Med Hyg. 1999;93:283–6. doi: 10.1016/s0035-9203(99)90024-x.</cite> [<a href="https://doi.org/10.1016/s0035-9203(99)90024-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10492760/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trans%20R%20Soc%20Trop%20Med%20Hyg&amp;title=Bacteraemia%20complicating%20severe%20malaria%20in%20children&amp;author=J%20Berkley&amp;author=S%20Mwarumba&amp;author=K%20Bramham&amp;author=B%20Lowe&amp;author=K%20Marsh&amp;volume=93&amp;publication_year=1999&amp;pages=283-6&amp;pmid=10492760&amp;doi=10.1016/s0035-9203(99)90024-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b36">
<span class="label">36.</span><cite>Molyneux ME, Taylor TE, Wirima JJ, Borgstein A. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med. 1989;71:441–59.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/2690177/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Q%20J%20Med&amp;title=Clinical%20features%20and%20prognostic%20indicators%20in%20paediatric%20cerebral%20malaria:%20a%20study%20of%20131%20comatose%20Malawian%20children&amp;author=ME%20Molyneux&amp;author=TE%20Taylor&amp;author=JJ%20Wirima&amp;author=A%20Borgstein&amp;volume=71&amp;publication_year=1989&amp;pages=441-59&amp;pmid=2690177&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b37">
<span class="label">37.</span><cite>Newton CR, Chokwe T, Schellenberg JA, Winstanley PA, Forster D, Peshu N, Kirkham FJ, Marsh K. Coma scales for children with severe falciparum malaria. Trans R Soc Trop Med Hyg. 1997;91:161–5. doi: 10.1016/s0035-9203(97)90207-8.</cite> [<a href="https://doi.org/10.1016/s0035-9203(97)90207-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9196757/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trans%20R%20Soc%20Trop%20Med%20Hyg&amp;title=Coma%20scales%20for%20children%20with%20severe%20falciparum%20malaria&amp;author=CR%20Newton&amp;author=T%20Chokwe&amp;author=JA%20Schellenberg&amp;author=PA%20Winstanley&amp;author=D%20Forster&amp;volume=91&amp;publication_year=1997&amp;pages=161-5&amp;pmid=9196757&amp;doi=10.1016/s0035-9203(97)90207-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b38">
<span class="label">38.</span><cite>Muchohi SN, Obiero K, Kokwaro GO, Ogutu BR, Githiga IM, Edwards G, Newton CR. Determination of lorazepam in plasma from children by high-performance liquid chromatography with UV detection. J Chromatogr B Anal Technol Biomed Life Sci. 2005;824:333–40. doi: 10.1016/j.jchromb.2005.07.040.</cite> [<a href="https://doi.org/10.1016/j.jchromb.2005.07.040" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16112623/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Chromatogr%20B%20Anal%20Technol%20Biomed%20Life%20Sci&amp;title=Determination%20of%20lorazepam%20in%20plasma%20from%20children%20by%20high-performance%20liquid%20chromatography%20with%20UV%20detection&amp;author=SN%20Muchohi&amp;author=K%20Obiero&amp;author=GO%20Kokwaro&amp;author=BR%20Ogutu&amp;author=IM%20Githiga&amp;volume=824&amp;publication_year=2005&amp;pages=333-40&amp;pmid=16112623&amp;doi=10.1016/j.jchromb.2005.07.040&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b39">
<span class="label">39.</span><cite>Rowland M, Tozer T.  Clinical Pharmacokinetics: Concepts and Applications. 2. Philadelphia: Lea &amp; Febiger; 1989. pp. 347–75.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Clinical%20Pharmacokinetics:%20Concepts%20and%20Applications&amp;author=M%20Rowland&amp;author=T%20Tozer&amp;publication_year=1989&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b40">
<span class="label">40.</span><cite>Heinzel G, Woloszczak R, Thomann P.  TopFit Version 2.0: Pharmacokinetic and Pharmacodynamic Data Analysis System for the PC. Stuttgart: Gustav Fischer, Schering AG; 1993. </cite> [<a href="https://scholar.google.com/scholar_lookup?title=TopFit%20Version%202.0:%20Pharmacokinetic%20and%20Pharmacodynamic%20Data%20Analysis%20System%20for%20the%20PC&amp;author=G%20Heinzel&amp;author=R%20Woloszczak&amp;author=P%20Thomann&amp;publication_year=1993&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b41">
<span class="label">41.</span><cite>Gibaldi M, Perrier DG.  Pharmacokinetics. 2. New York: Marcel Dekker; 1982. </cite> [<a href="https://scholar.google.com/scholar_lookup?title=Pharmacokinetics&amp;author=M%20Gibaldi&amp;author=DG%20Perrier&amp;publication_year=1982&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b42">
<span class="label">42.</span><cite>Yamaoka K, Nakagawa T, Uno T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm. 1978;6:165–75. doi: 10.1007/BF01117450.</cite> [<a href="https://doi.org/10.1007/BF01117450" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/671222/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pharmacokinet%20Biopharm&amp;title=Application%20of%20Akaike's%20information%20criterion%20(AIC)%20in%20the%20evaluation%20of%20linear%20pharmacokinetic%20equations&amp;author=K%20Yamaoka&amp;author=T%20Nakagawa&amp;author=T%20Uno&amp;volume=6&amp;publication_year=1978&amp;pages=165-75&amp;pmid=671222&amp;doi=10.1007/BF01117450&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b43">
<span class="label">43.</span><cite>Altman DG, Machin D, Bryant TN, Gardner MJ.  Statistics with Confidence. 2. London: BMJ Books; 2000. </cite> [<a href="https://scholar.google.com/scholar_lookup?title=Statistics%20with%20Confidence&amp;author=DG%20Altman&amp;author=D%20Machin&amp;author=TN%20Bryant&amp;author=MJ%20Gardner&amp;publication_year=2000&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b44">
<span class="label">44.</span><cite>Greenblatt DJ, Comer WH, Elliott HW, Shader RI, Knowles JA, Ruelius HW. Clinical pharmacokinetics of lorazepam. III. Intravenous injection. Preliminary results. J Clin Pharmacol. 1977;17:490–4. doi: 10.1002/j.1552-4604.1977.tb05641.x.</cite> [<a href="https://doi.org/10.1002/j.1552-4604.1977.tb05641.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19508/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Pharmacol&amp;title=Clinical%20pharmacokinetics%20of%20lorazepam.%20III.%20Intravenous%20injection.%20Preliminary%20results&amp;author=DJ%20Greenblatt&amp;author=WH%20Comer&amp;author=HW%20Elliott&amp;author=RI%20Shader&amp;author=JA%20Knowles&amp;volume=17&amp;publication_year=1977&amp;pages=490-4&amp;pmid=19508&amp;doi=10.1002/j.1552-4604.1977.tb05641.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b45">
<span class="label">45.</span><cite>Greenblatt DJ, Joyce TH, Comer WH, Knowles JA, Shader RI, Kyriakopoulos AA, MacLaughlin DS, Ruelius HW. Clinical pharmacokinetics of lorazepam. II. Intramuscular injection. Clin Pharmacol Ther. 1977;21:222–30. doi: 10.1002/cpt1977212222.</cite> [<a href="https://doi.org/10.1002/cpt1977212222" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/13960/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Pharmacol%20Ther&amp;title=Clinical%20pharmacokinetics%20of%20lorazepam.%20II.%20Intramuscular%20injection&amp;author=DJ%20Greenblatt&amp;author=TH%20Joyce&amp;author=WH%20Comer&amp;author=JA%20Knowles&amp;author=RI%20Shader&amp;volume=21&amp;publication_year=1977&amp;pages=222-30&amp;pmid=13960&amp;doi=10.1002/cpt1977212222&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b46">
<span class="label">46.</span><cite>McDermott CA, Kowalczyk AL, Schnitzler ER, Mangurten HH, Rodvold KA, Metrick S. Pharmacokinetics of lorazepam in critically ill neonates with seizures. J Pediatr. 1992;120:479–83. doi: 10.1016/s0022-3476(05)80925-4.</cite> [<a href="https://doi.org/10.1016/s0022-3476(05)80925-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1538303/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pediatr&amp;title=Pharmacokinetics%20of%20lorazepam%20in%20critically%20ill%20neonates%20with%20seizures&amp;author=CA%20McDermott&amp;author=AL%20Kowalczyk&amp;author=ER%20Schnitzler&amp;author=HH%20Mangurten&amp;author=KA%20Rodvold&amp;volume=120&amp;publication_year=1992&amp;pages=479-83&amp;pmid=1538303&amp;doi=10.1016/s0022-3476(05)80925-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b47">
<span class="label">47.</span><cite>Relling MV, Mulhern RK, Dodge RK, Johnson D, Pieper JA, Rivera GK, Evans WE. Lorazepam pharmacodynamics and pharmacokinetics in children. J Pediatr. 1989;114:641–6. doi: 10.1016/s0022-3476(89)80713-9.</cite> [<a href="https://doi.org/10.1016/s0022-3476(89)80713-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2926577/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pediatr&amp;title=Lorazepam%20pharmacodynamics%20and%20pharmacokinetics%20in%20children&amp;author=MV%20Relling&amp;author=RK%20Mulhern&amp;author=RK%20Dodge&amp;author=D%20Johnson&amp;author=JA%20Pieper&amp;volume=114&amp;publication_year=1989&amp;pages=641-6&amp;pmid=2926577&amp;doi=10.1016/s0022-3476(89)80713-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b48">
<span class="label">48.</span><cite>Swart EL, Zuideveld KP, de Jongh J, Danhof M, Thijs LG, Strack van Schijndel RM. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients. Br J Clin Pharmacol. 2004;57:135–45. doi: 10.1046/j.1365-2125.2003.01957.x.</cite> [<a href="https://doi.org/10.1046/j.1365-2125.2003.01957.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1884441/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14748812/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Clin%20Pharmacol&amp;title=Comparative%20population%20pharmacokinetics%20of%20lorazepam%20and%20midazolam%20during%20long-term%20continuous%20infusion%20in%20critically%20ill%20patients&amp;author=EL%20Swart&amp;author=KP%20Zuideveld&amp;author=J%20de%20Jongh&amp;author=M%20Danhof&amp;author=LG%20Thijs&amp;volume=57&amp;publication_year=2004&amp;pages=135-45&amp;pmid=14748812&amp;doi=10.1046/j.1365-2125.2003.01957.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b49">
<span class="label">49.</span><cite>Giang DW, McBride MC. Lorazepam versus diazepam for the treatment of status epilepticus. Pediatr Neurol. 1988;4:358–61. doi: 10.1016/0887-8994(88)90083-5.</cite> [<a href="https://doi.org/10.1016/0887-8994(88)90083-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3245874/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr%20Neurol&amp;title=Lorazepam%20versus%20diazepam%20for%20the%20treatment%20of%20status%20epilepticus&amp;author=DW%20Giang&amp;author=MC%20McBride&amp;volume=4&amp;publication_year=1988&amp;pages=358-61&amp;pmid=3245874&amp;doi=10.1016/0887-8994(88)90083-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b50">
<span class="label">50.</span><cite>Idro R, Jenkins NE, Newton CR. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol. 2005;4:827–40. doi: 10.1016/S1474-4422(05)70247-7.</cite> [<a href="https://doi.org/10.1016/S1474-4422(05)70247-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16297841/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Neurol&amp;title=Pathogenesis,%20clinical%20features,%20and%20neurological%20outcome%20of%20cerebral%20malaria&amp;author=R%20Idro&amp;author=NE%20Jenkins&amp;author=CR%20Newton&amp;volume=4&amp;publication_year=2005&amp;pages=827-40&amp;pmid=16297841&amp;doi=10.1016/S1474-4422(05)70247-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b51">
<span class="label">51.</span><cite>Verbeeck RK, Branch RA, Wilkinson GR. Drug metabolites in renal failure: pharmacokinetic and clinical implications. Clin Pharmacokinet. 1981;6:329–45. doi: 10.2165/00003088-198106050-00001.</cite> [<a href="https://doi.org/10.2165/00003088-198106050-00001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7037261/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Pharmacokinet&amp;title=Drug%20metabolites%20in%20renal%20failure:%20pharmacokinetic%20and%20clinical%20implications&amp;author=RK%20Verbeeck&amp;author=RA%20Branch&amp;author=GR%20Wilkinson&amp;volume=6&amp;publication_year=1981&amp;pages=329-45&amp;pmid=7037261&amp;doi=10.2165/00003088-198106050-00001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b52">
<span class="label">52.</span><cite>Cummings AJ, King ML, Martin BK. A kinetic study of drug elimination: the excretion of paracetamol and its metabolites in man. Br J Pharmacol Chemother. 1967;29:150–7. doi: 10.1111/j.1476-5381.1967.tb01948.x.</cite> [<a href="https://doi.org/10.1111/j.1476-5381.1967.tb01948.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1557197/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6032053/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Pharmacol%20Chemother&amp;title=A%20kinetic%20study%20of%20drug%20elimination:%20the%20excretion%20of%20paracetamol%20and%20its%20metabolites%20in%20man&amp;author=AJ%20Cummings&amp;author=ML%20King&amp;author=BK%20Martin&amp;volume=29&amp;publication_year=1967&amp;pages=150-7&amp;pmid=6032053&amp;doi=10.1111/j.1476-5381.1967.tb01948.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b53">
<span class="label">53.</span><cite>Graves NM, Kriel RL, Jones-Saete C. Bioavailability of rectally administered lorazepam. Clin Neuropharmacol. 1987;10:555–9. doi: 10.1097/00002826-198712000-00007.</cite> [<a href="https://doi.org/10.1097/00002826-198712000-00007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3427562/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Neuropharmacol&amp;title=Bioavailability%20of%20rectally%20administered%20lorazepam&amp;author=NM%20Graves&amp;author=RL%20Kriel&amp;author=C%20Jones-Saete&amp;volume=10&amp;publication_year=1987&amp;pages=555-9&amp;pmid=3427562&amp;doi=10.1097/00002826-198712000-00007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b54">
<span class="label">54.</span><cite>Scott RC, Besag FM, Neville BG. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet. 1999;353:623–6. doi: 10.1016/S0140-6736(98)06425-3.</cite> [<a href="https://doi.org/10.1016/S0140-6736(98)06425-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10030327/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Buccal%20midazolam%20and%20rectal%20diazepam%20for%20treatment%20of%20prolonged%20seizures%20in%20childhood%20and%20adolescence:%20a%20randomised%20trial&amp;author=RC%20Scott&amp;author=FM%20Besag&amp;author=BG%20Neville&amp;volume=353&amp;publication_year=1999&amp;pages=623-6&amp;pmid=10030327&amp;doi=10.1016/S0140-6736(98)06425-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b55">
<span class="label">55.</span><cite>McIntyre J, Robertson S, Norris E, Appleton R, Whitehouse WP, Phillips B, Martland T, Berry K, Collier J, Smith S, Choonara I. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet. 2005;366:205–10. doi: 10.1016/S0140-6736(05)66909-7.</cite> [<a href="https://doi.org/10.1016/S0140-6736(05)66909-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16023510/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Safety%20and%20efficacy%20of%20buccal%20midazolam%20versus%20rectal%20diazepam%20for%20emergency%20treatment%20of%20seizures%20in%20children:%20a%20randomised%20controlled%20trial&amp;author=J%20McIntyre&amp;author=S%20Robertson&amp;author=E%20Norris&amp;author=R%20Appleton&amp;author=WP%20Whitehouse&amp;volume=366&amp;publication_year=2005&amp;pages=205-10&amp;pmid=16023510&amp;doi=10.1016/S0140-6736(05)66909-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from British Journal of Clinical Pharmacology are provided here courtesy of <strong>British Pharmacological Society</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1111/j.1365-2125.2007.02966.x"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/bcp0065-0012.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (889.1 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/2291276/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/2291276/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC2291276%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC2291276/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC2291276/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC2291276/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/17635501/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC2291276/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/17635501/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC2291276/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/2291276/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="1nDYZ0qKM4iOdCA1oJliyuTwK9HghkEstgYBlEHmghaPzsjvSUPWAQaJHErEkSZN">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-6f05ef93.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-69f9d1ae.js"></script>
    
    

    </body>
</html>